MXPA97005403A - Methods, compositions and distribuciondental systems for the protection of dien surfaces - Google Patents
Methods, compositions and distribuciondental systems for the protection of dien surfacesInfo
- Publication number
- MXPA97005403A MXPA97005403A MXPA/A/1997/005403A MX9705403A MXPA97005403A MX PA97005403 A MXPA97005403 A MX PA97005403A MX 9705403 A MX9705403 A MX 9705403A MX PA97005403 A MXPA97005403 A MX PA97005403A
- Authority
- MX
- Mexico
- Prior art keywords
- chlorophenol
- methyl
- phenol
- resorcinol
- dimethyl
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims description 115
- RPNUMPOLZDHAAY-UHFFFAOYSA-N DETA Chemical compound NCCNCCN RPNUMPOLZDHAAY-UHFFFAOYSA-N 0.000 title 1
- 239000000463 material Substances 0.000 claims abstract description 134
- 150000001875 compounds Chemical class 0.000 claims abstract description 34
- 125000002091 cationic group Chemical group 0.000 claims abstract description 22
- 210000000515 Tooth Anatomy 0.000 claims description 142
- -1 ethylene biguanides Chemical class 0.000 claims description 127
- 239000003795 chemical substances by application Substances 0.000 claims description 92
- 125000004433 nitrogen atoms Chemical group N* 0.000 claims description 43
- 239000001993 wax Substances 0.000 claims description 38
- 125000000217 alkyl group Chemical group 0.000 claims description 31
- 229920002873 Polyethylenimine Polymers 0.000 claims description 29
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 28
- 239000000194 fatty acid Substances 0.000 claims description 28
- 239000004200 microcrystalline wax Substances 0.000 claims description 24
- 235000019808 microcrystalline wax Nutrition 0.000 claims description 24
- KRHYYFGTRYWZRS-UHFFFAOYSA-M fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims description 23
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 22
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 21
- 238000006243 chemical reaction Methods 0.000 claims description 20
- 150000001412 amines Chemical class 0.000 claims description 17
- DTOUUUZOYKYHEP-UHFFFAOYSA-N 1,3-bis(2-ethylhexyl)-5-methyl-1,3-diazinan-5-amine Chemical group CCCCC(CC)CN1CN(CC(CC)CCCC)CC(C)(N)C1 DTOUUUZOYKYHEP-UHFFFAOYSA-N 0.000 claims description 15
- 229920002401 polyacrylamide Polymers 0.000 claims description 15
- 239000000758 substrate Substances 0.000 claims description 15
- 235000019271 petrolatum Nutrition 0.000 claims description 14
- 229920000642 polymer Polymers 0.000 claims description 14
- 229960004830 Cetylpyridinium Drugs 0.000 claims description 13
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims description 13
- 239000004810 polytetrafluoroethylene Substances 0.000 claims description 13
- YFWDLDXZEGVVIL-UHFFFAOYSA-N 1-(2-ethylhexyl)-5-methyl-1,3-diazinane Chemical compound CCCCC(CC)CN1CNCC(C)C1 YFWDLDXZEGVVIL-UHFFFAOYSA-N 0.000 claims description 12
- NEUSVAOJNUQRTM-UHFFFAOYSA-N cetylpyridinium Chemical group CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 NEUSVAOJNUQRTM-UHFFFAOYSA-N 0.000 claims description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-M chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 12
- 150000004665 fatty acids Chemical class 0.000 claims description 12
- 229920000768 polyamine Polymers 0.000 claims description 12
- 239000008079 hexane Substances 0.000 claims description 11
- 239000011737 fluorine Substances 0.000 claims description 10
- 229910052731 fluorine Inorganic materials 0.000 claims description 10
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 claims description 10
- 239000004952 Polyamide Substances 0.000 claims description 9
- 239000001257 hydrogen Substances 0.000 claims description 9
- 229910052739 hydrogen Inorganic materials 0.000 claims description 9
- 229920002647 polyamide Polymers 0.000 claims description 9
- UREZNYTWGJKWBI-UHFFFAOYSA-M Benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 claims description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 8
- NROKBHXJSPEDAR-UHFFFAOYSA-M Potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 claims description 8
- 235000013871 bee wax Nutrition 0.000 claims description 8
- 239000012166 beeswax Substances 0.000 claims description 8
- 239000004203 carnauba wax Substances 0.000 claims description 8
- 235000013869 carnauba wax Nutrition 0.000 claims description 8
- 229920002620 polyvinyl fluoride Polymers 0.000 claims description 8
- 229920002717 polyvinylpyridine Polymers 0.000 claims description 8
- GUBGYTABKSRVRQ-WFVLMXAXSA-N (6S)-2-(hydroxymethyl)-6-{[(3S)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}oxane-3,4,5-triol Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 claims description 7
- GKQHIYSTBXDYNQ-UHFFFAOYSA-M 1-dodecylpyridin-1-ium;chloride Chemical group [Cl-].CCCCCCCCCCCC[N+]1=CC=CC=C1 GKQHIYSTBXDYNQ-UHFFFAOYSA-M 0.000 claims description 7
- NCKMMSIFQUPKCK-UHFFFAOYSA-N 2-benzyl-4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1CC1=CC=CC=C1 NCKMMSIFQUPKCK-UHFFFAOYSA-N 0.000 claims description 7
- 229920001425 Diethylaminoethyl cellulose Polymers 0.000 claims description 7
- 239000004166 Lanolin Substances 0.000 claims description 7
- 229940039717 Lanolin Drugs 0.000 claims description 7
- IWDCLRJOBJJRNH-UHFFFAOYSA-N P-Cresol Chemical compound CC1=CC=C(O)C=C1 IWDCLRJOBJJRNH-UHFFFAOYSA-N 0.000 claims description 7
- 239000004264 Petrolatum Substances 0.000 claims description 7
- 229940066842 Petrolatum Drugs 0.000 claims description 7
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 7
- ICUTUKXCWQYESQ-UHFFFAOYSA-N Triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 claims description 7
- 150000002148 esters Chemical class 0.000 claims description 7
- 150000004820 halides Chemical class 0.000 claims description 7
- 125000004435 hydrogen atoms Chemical class [H]* 0.000 claims description 7
- 235000019388 lanolin Nutrition 0.000 claims description 7
- 239000012188 paraffin wax Substances 0.000 claims description 7
- 235000019809 paraffin wax Nutrition 0.000 claims description 7
- 229920000083 poly(allylamine) Polymers 0.000 claims description 7
- 229920000371 poly(diallyldimethylammonium chloride) polymer Polymers 0.000 claims description 7
- 229920000573 polyethylene Polymers 0.000 claims description 7
- 229920001184 polypeptide Polymers 0.000 claims description 7
- 229920002981 polyvinylidene fluoride Polymers 0.000 claims description 7
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 7
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 7
- 229920002413 Polyhexanide Polymers 0.000 claims description 6
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 6
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 6
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 6
- VYKKDKFTDMVOBU-UHFFFAOYSA-N 3,5-dibromo-2-hydroxy-N-[3-(trifluoromethyl)phenyl]benzamide Chemical compound OC1=C(Br)C=C(Br)C=C1C(=O)NC1=CC=CC(C(F)(F)F)=C1 VYKKDKFTDMVOBU-UHFFFAOYSA-N 0.000 claims description 5
- SFVFIFLLYFPGHH-UHFFFAOYSA-M Stearalkonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 SFVFIFLLYFPGHH-UHFFFAOYSA-M 0.000 claims description 5
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 5
- WKBOTKDWSSQWDR-UHFFFAOYSA-N bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 5
- 239000000460 chlorine Chemical group 0.000 claims description 5
- 229910052801 chlorine Chemical group 0.000 claims description 5
- ZAMOUSCENKQFHK-UHFFFAOYSA-N chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 5
- 239000011775 sodium fluoride Substances 0.000 claims description 5
- 235000013024 sodium fluoride Nutrition 0.000 claims description 5
- ZFSXZJXLKAJIGS-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[4-chloro-3-(trifluoromethyl)phenyl]urea Chemical compound C1=C(Cl)C(C(F)(F)F)=CC(NC(=O)NC=2C=CC(Cl)=CC=2)=C1 ZFSXZJXLKAJIGS-UHFFFAOYSA-N 0.000 claims description 4
- ACTOXUHEUCPTEW-BOISPSKTSA-N 2-[(4R,5S,6S,7R,9R,10R,11E,13E,16S)-6-[(2S,3R,4R,5S,6R)-5-[(2S,4R,5R,6S)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-10-[(2R,5S,6R)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-4-hydroxy-5-methoxy-9,16-dimethyl-2-o Chemical compound O([C@H]1/C=C/C=C/C[C@H](C)OC(=O)C[C@@H](O)[C@@H]([C@H]([C@@H](CC=O)C[C@H]1C)O[C@H]1[C@@H]([C@H]([C@H](O[C@@H]2O[C@@H](C)[C@@H](O)[C@](C)(O)C2)[C@@H](C)O1)N(C)C)O)OC)[C@H]1CC[C@H](N(C)C)[C@@H](C)O1 ACTOXUHEUCPTEW-BOISPSKTSA-N 0.000 claims description 4
- UOWIFEANNONTKY-UHFFFAOYSA-N 2-hydroxy-5-octanoyl-N-[3-(trifluoromethyl)phenyl]benzamide Chemical compound CCCCCCCC(=O)C1=CC=C(O)C(C(=O)NC=2C=C(C=CC=2)C(F)(F)F)=C1 UOWIFEANNONTKY-UHFFFAOYSA-N 0.000 claims description 4
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-oxazolidone Chemical class O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 claims description 4
- QALJHHQKMLSUME-UHFFFAOYSA-N 3,5,5-trichloro-N-(3-chlorophenyl)-6-hydroxycyclohexa-1,3-diene-1-carboxamide Chemical compound ClC1=CC(Cl)(Cl)C(O)C(C(=O)NC=2C=C(Cl)C=CC=2)=C1 QALJHHQKMLSUME-UHFFFAOYSA-N 0.000 claims description 4
- YJESMCOKCBFYBX-UHFFFAOYSA-N 3,5,6-trichloro-N-(3-chlorophenyl)-6-hydroxycyclohexa-2,4-diene-1-carboxamide Chemical compound C1=C(Cl)C=C(Cl)C(O)(Cl)C1C(=O)NC1=CC=CC(Cl)=C1 YJESMCOKCBFYBX-UHFFFAOYSA-N 0.000 claims description 4
- FLYZSJGIJYEAFV-UHFFFAOYSA-N 3,5-dibromo-2-hydroxy-N-[4-(trifluoromethyl)phenyl]benzamide Chemical compound OC1=C(Br)C=C(Br)C=C1C(=O)NC1=CC=C(C(F)(F)F)C=C1 FLYZSJGIJYEAFV-UHFFFAOYSA-N 0.000 claims description 4
- USFZGCVGLNMJPL-UHFFFAOYSA-N 3,5-dichloro-N-(4-chlorophenyl)-2-hydroxybenzamide Chemical compound OC1=C(Cl)C=C(Cl)C=C1C(=O)NC1=CC=C(Cl)C=C1 USFZGCVGLNMJPL-UHFFFAOYSA-N 0.000 claims description 4
- NBJOEVNMBJIEBA-UHFFFAOYSA-N 4-bromo-2-hexylphenol Chemical compound CCCCCCC1=CC(Br)=CC=C1O NBJOEVNMBJIEBA-UHFFFAOYSA-N 0.000 claims description 4
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims description 4
- CTFFKFYWSOSIAA-UHFFFAOYSA-N 5-bromo-N-(4-bromophenyl)-2-hydroxybenzamide Chemical compound OC1=CC=C(Br)C=C1C(=O)NC1=CC=C(Br)C=C1 CTFFKFYWSOSIAA-UHFFFAOYSA-N 0.000 claims description 4
- 229960001950 Benzethonium Chloride Drugs 0.000 claims description 4
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 claims description 4
- SBUJHOSQTJFQJX-NOAMYHISSA-N Kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 claims description 4
- 229960000282 Metronidazole Drugs 0.000 claims description 4
- QWVGKYWNOKOFNN-UHFFFAOYSA-N O-Cresol Chemical compound CC1=CC=CC=C1O QWVGKYWNOKOFNN-UHFFFAOYSA-N 0.000 claims description 4
- 229940049954 Penicillin Drugs 0.000 claims description 4
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims description 4
- 108010093965 Polymyxin B Proteins 0.000 claims description 4
- GHMLBKRAJCXXBS-UHFFFAOYSA-N Resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 claims description 4
- TWGUZEUZLCYTCG-UHFFFAOYSA-N Sodium fluorosilicate Chemical compound [Na+].[Na+].F[Si-2](F)(F)(F)(F)F TWGUZEUZLCYTCG-UHFFFAOYSA-N 0.000 claims description 4
- BFDWBSRJQZPEEB-UHFFFAOYSA-L Sodium monofluorophosphate Chemical compound [Na+].[Na+].[O-]P([O-])(F)=O BFDWBSRJQZPEEB-UHFFFAOYSA-L 0.000 claims description 4
- 239000004187 Spiramycin Substances 0.000 claims description 4
- 229960002180 Tetracycline Drugs 0.000 claims description 4
- OFVLGDICTFRJMM-WESIUVDSSA-N Tetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O OFVLGDICTFRJMM-WESIUVDSSA-N 0.000 claims description 4
- 239000004098 Tetracycline Substances 0.000 claims description 4
- MGSRCZKZVOBKFT-UHFFFAOYSA-N Thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 claims description 4
- YUOWTJMRMWQJDA-UHFFFAOYSA-J Tin(IV) fluoride Chemical compound [F-].[F-].[F-].[F-].[Sn+4] YUOWTJMRMWQJDA-UHFFFAOYSA-J 0.000 claims description 4
- MYPYJXKWCTUITO-LYRMYLQWSA-N VANCOMYCIN Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 claims description 4
- 229960003165 Vancomycin Drugs 0.000 claims description 4
- 108010059993 Vancomycin Proteins 0.000 claims description 4
- BHHYHSUAOQUXJK-UHFFFAOYSA-L Zinc fluoride Chemical compound F[Zn]F BHHYHSUAOQUXJK-UHFFFAOYSA-L 0.000 claims description 4
- 229960000626 benzylpenicillin Drugs 0.000 claims description 4
- UUHPPUWEDCVPCO-UHFFFAOYSA-N dipotassium;hexafluorosilicon(2-) Chemical compound [K+].[K+].F[Si-2](F)(F)(F)(F)F UUHPPUWEDCVPCO-UHFFFAOYSA-N 0.000 claims description 4
- 229960003276 erythromycin Drugs 0.000 claims description 4
- 229960000318 kanamycin Drugs 0.000 claims description 4
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 claims description 4
- 229960005266 polymyxin B Drugs 0.000 claims description 4
- 229920000024 polymyxin B Polymers 0.000 claims description 4
- 239000011698 potassium fluoride Substances 0.000 claims description 4
- 235000003270 potassium fluoride Nutrition 0.000 claims description 4
- 229960001294 spiramycin Drugs 0.000 claims description 4
- 235000019372 spiramycin Nutrition 0.000 claims description 4
- 235000019364 tetracycline Nutrition 0.000 claims description 4
- 229930007823 thymol Natural products 0.000 claims description 4
- KVSKGMLNBAPGKH-UHFFFAOYSA-N tribromosalicylanilide Chemical compound OC1=C(Br)C=C(Br)C=C1C(=O)NC1=CC=C(Br)C=C1 KVSKGMLNBAPGKH-UHFFFAOYSA-N 0.000 claims description 4
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 claims description 3
- RZULCOZWGAMDSN-UHFFFAOYSA-N N-fluorohexadecan-1-amine Chemical compound CCCCCCCCCCCCCCCCNF RZULCOZWGAMDSN-UHFFFAOYSA-N 0.000 claims description 3
- 229910052718 tin Inorganic materials 0.000 claims description 3
- ATJFFYVFTNAWJD-UHFFFAOYSA-N tin hydride Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims description 3
- JFIOVJDNOJYLKP-UHFFFAOYSA-N Bithionol Chemical compound OC1=C(Cl)C=C(Cl)C=C1SC1=CC(Cl)=CC(Cl)=C1O JFIOVJDNOJYLKP-UHFFFAOYSA-N 0.000 claims description 2
- 229920000209 Hexadimethrine bromide Polymers 0.000 claims description 2
- 229940058933 biguanide antimalarials Drugs 0.000 claims description 2
- 229940090145 biguanide blood glucose lower drugs Drugs 0.000 claims description 2
- GFIKIVSYJDVOOZ-UHFFFAOYSA-L calcium;fluoro-dioxido-oxo-$l^{5}-phosphane Chemical compound [Ca+2].[O-]P([O-])(F)=O GFIKIVSYJDVOOZ-UHFFFAOYSA-L 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 125000001153 fluoro group Chemical group F* 0.000 claims 12
- 229960001927 Cetylpyridinium Chloride Drugs 0.000 claims 9
- YMKDRGPMQRFJGP-UHFFFAOYSA-M Cetylpyridinium chloride Chemical group [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 claims 9
- DVBJBNKEBPCGSY-UHFFFAOYSA-M cetylpyridinium bromide Chemical group [Br-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 DVBJBNKEBPCGSY-UHFFFAOYSA-M 0.000 claims 9
- PNXWPUCNFMVBBK-UHFFFAOYSA-M 1-dodecylpyridin-1-ium;bromide Chemical group [Br-].CCCCCCCCCCCC[N+]1=CC=CC=C1 PNXWPUCNFMVBBK-UHFFFAOYSA-M 0.000 claims 6
- RHPUJHQBPORFGV-UHFFFAOYSA-N 4-chloro-2-methylphenol Chemical compound CC1=CC(Cl)=CC=C1O RHPUJHQBPORFGV-UHFFFAOYSA-N 0.000 claims 6
- OSDLLIBGSJNGJE-UHFFFAOYSA-N Chloroxylenol Chemical compound CC1=CC(O)=CC(C)=C1Cl OSDLLIBGSJNGJE-UHFFFAOYSA-N 0.000 claims 6
- 239000002033 PVDF binder Substances 0.000 claims 6
- 125000003118 aryl group Chemical group 0.000 claims 6
- 125000001309 chloro group Chemical group Cl* 0.000 claims 6
- 239000003209 petroleum derivative Substances 0.000 claims 6
- CFKMVGJGLGKFKI-UHFFFAOYSA-N P-Chlorocresol Chemical compound CC1=CC(O)=CC=C1Cl CFKMVGJGLGKFKI-UHFFFAOYSA-N 0.000 claims 5
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 3
- GGIDUULRWQOXLR-UHFFFAOYSA-N 2,3,4,5-tetrabromo-6-methylphenol Chemical compound CC1=C(O)C(Br)=C(Br)C(Br)=C1Br GGIDUULRWQOXLR-UHFFFAOYSA-N 0.000 claims 3
- KUFFULVDNCHOFZ-UHFFFAOYSA-N 2,4-Dimethylphenol Chemical compound CC1=CC=C(O)C(C)=C1 KUFFULVDNCHOFZ-UHFFFAOYSA-N 0.000 claims 3
- IYOLBFFHPZOQGW-UHFFFAOYSA-N 2,4-dichloro-3,5-dimethylphenol Chemical compound CC1=CC(O)=C(Cl)C(C)=C1Cl IYOLBFFHPZOQGW-UHFFFAOYSA-N 0.000 claims 3
- NKTOLZVEWDHZMU-UHFFFAOYSA-N 2,5-dimethylphenol Chemical compound CC1=CC=C(C)C(O)=C1 NKTOLZVEWDHZMU-UHFFFAOYSA-N 0.000 claims 3
- NXXYKOUNUYWIHA-UHFFFAOYSA-N 2,6-Xylenol Chemical compound CC1=CC=CC(C)=C1O NXXYKOUNUYWIHA-UHFFFAOYSA-N 0.000 claims 3
- CFSOXRGHLCXRNB-UHFFFAOYSA-N 2-(3-phenylpropyl)benzene-1,3-diol Chemical compound OC1=CC=CC(O)=C1CCCC1=CC=CC=C1 CFSOXRGHLCXRNB-UHFFFAOYSA-N 0.000 claims 3
- LLEMOWNGBBNAJR-UHFFFAOYSA-N 2-Phenylphenol Chemical compound OC1=CC=CC=C1C1=CC=CC=C1 LLEMOWNGBBNAJR-UHFFFAOYSA-N 0.000 claims 3
- IYXUFNCIWJHFBR-UHFFFAOYSA-N 2-benzyl-4-chloro-3-methylphenol Chemical compound CC1=C(Cl)C=CC(O)=C1CC1=CC=CC=C1 IYXUFNCIWJHFBR-UHFFFAOYSA-N 0.000 claims 3
- WPMBXQJYQZTSGS-UHFFFAOYSA-N 2-benzyl-4-chlorobenzene-1,3-diol Chemical compound OC1=CC=C(Cl)C(O)=C1CC1=CC=CC=C1 WPMBXQJYQZTSGS-UHFFFAOYSA-N 0.000 claims 3
- RKDMDAVSHRCXQZ-UHFFFAOYSA-N 2-benzylbenzene-1,3-diol Chemical compound OC1=CC=CC(O)=C1CC1=CC=CC=C1 RKDMDAVSHRCXQZ-UHFFFAOYSA-N 0.000 claims 3
- COVGKJSMQVFLDP-UHFFFAOYSA-N 2-bromo-3-hexylphenol Chemical compound CCCCCCC1=CC=CC(O)=C1Br COVGKJSMQVFLDP-UHFFFAOYSA-N 0.000 claims 3
- TYBHZVUFOINFDV-UHFFFAOYSA-N 2-bromo-6-[(3-bromo-5-chloro-2-hydroxyphenyl)methyl]-4-chlorophenol Chemical compound OC1=C(Br)C=C(Cl)C=C1CC1=CC(Cl)=CC(Br)=C1O TYBHZVUFOINFDV-UHFFFAOYSA-N 0.000 claims 3
- BRYHBLAGEXUHSL-UHFFFAOYSA-N 2-butan-2-yl-4-chloro-5-methylphenol Chemical compound CCC(C)C1=CC(Cl)=C(C)C=C1O BRYHBLAGEXUHSL-UHFFFAOYSA-N 0.000 claims 3
- COSYXLHTXXMVGM-UHFFFAOYSA-N 2-butyl-4-chlorophenol Chemical compound CCCCC1=CC(Cl)=CC=C1O COSYXLHTXXMVGM-UHFFFAOYSA-N 0.000 claims 3
- NVIHKOLBNJOVTD-UHFFFAOYSA-N 2-chloro-3-heptylphenol Chemical compound CCCCCCCC1=CC=CC(O)=C1Cl NVIHKOLBNJOVTD-UHFFFAOYSA-N 0.000 claims 3
- PFEPQLAKIAJJRQ-UHFFFAOYSA-N 2-chloro-3-hexylphenol Chemical compound CCCCCCC1=CC=CC(O)=C1Cl PFEPQLAKIAJJRQ-UHFFFAOYSA-N 0.000 claims 3
- DWVXFVWWARTDCQ-UHFFFAOYSA-N 2-ethylbenzene-1,3-diol Chemical compound CCC1=C(O)C=CC=C1O DWVXFVWWARTDCQ-UHFFFAOYSA-N 0.000 claims 3
- GOUWRHHYANYVLG-UHFFFAOYSA-N 2-heptylbenzene-1,3-diol Chemical compound CCCCCCCC1=C(O)C=CC=C1O GOUWRHHYANYVLG-UHFFFAOYSA-N 0.000 claims 3
- IEIHCSFJLQYKGJ-UHFFFAOYSA-N 2-nonylbenzene-1,3-diol Chemical compound CCCCCCCCCC1=C(O)C=CC=C1O IEIHCSFJLQYKGJ-UHFFFAOYSA-N 0.000 claims 3
- HHSCZZZCAYSVRK-UHFFFAOYSA-N 2-octylbenzene-1,3-diol Chemical compound CCCCCCCCC1=C(O)C=CC=C1O HHSCZZZCAYSVRK-UHFFFAOYSA-N 0.000 claims 3
- UPXZHXVOMCGZDS-UHFFFAOYSA-N 2-phenylbenzene-1,3-diol Chemical compound OC1=CC=CC(O)=C1C1=CC=CC=C1 UPXZHXVOMCGZDS-UHFFFAOYSA-N 0.000 claims 3
- 229940061334 2-phenylphenol Drugs 0.000 claims 3
- XDCMHOFEBFTMNL-UHFFFAOYSA-N 2-propylbenzene-1,3-diol Chemical compound CCCC1=C(O)C=CC=C1O XDCMHOFEBFTMNL-UHFFFAOYSA-N 0.000 claims 3
- OHWLDHSSZYNNLN-UHFFFAOYSA-M 2-pyridin-1-ium-1-ylpyridine;chloride Chemical compound [Cl-].C1=CC=CC=[N+]1C1=CC=CC=N1 OHWLDHSSZYNNLN-UHFFFAOYSA-M 0.000 claims 3
- YCOXTKKNXUZSKD-UHFFFAOYSA-N 3,4-Xylenol Chemical compound CC1=CC=C(O)C=C1C YCOXTKKNXUZSKD-UHFFFAOYSA-N 0.000 claims 3
- OAOFCENSKJNHQG-UHFFFAOYSA-N 3-butyl-2-chlorophenol Chemical compound CCCCC1=CC=CC(O)=C1Cl OAOFCENSKJNHQG-UHFFFAOYSA-N 0.000 claims 3
- XPNKJGMHGPTELE-UHFFFAOYSA-N 3-hexoxyphenol Chemical compound CCCCCCOC1=CC=CC(O)=C1 XPNKJGMHGPTELE-UHFFFAOYSA-N 0.000 claims 3
- PQSXNIMHIHYFEE-UHFFFAOYSA-N 4-(1-phenylethyl)benzene-1,3-diol Chemical compound C=1C=C(O)C=C(O)C=1C(C)C1=CC=CC=C1 PQSXNIMHIHYFEE-UHFFFAOYSA-N 0.000 claims 3
- HXDOZKJGKXYMEW-UHFFFAOYSA-N 4-Ethylphenol Chemical compound CCC1=CC=C(O)C=C1 HXDOZKJGKXYMEW-UHFFFAOYSA-N 0.000 claims 3
- KLSLBUSXWBJMEC-UHFFFAOYSA-N 4-Propylphenol Chemical compound CCCC1=CC=C(O)C=C1 KLSLBUSXWBJMEC-UHFFFAOYSA-N 0.000 claims 3
- ATVXBMXBDVUKPM-UHFFFAOYSA-N 4-bromo-2-butylphenol Chemical compound CCCCC1=CC(Br)=CC=C1O ATVXBMXBDVUKPM-UHFFFAOYSA-N 0.000 claims 3
- QQVRKOIEEIGPMK-UHFFFAOYSA-N 4-bromo-2-cyclohexylphenol Chemical compound OC1=CC=C(Br)C=C1C1CCCCC1 QQVRKOIEEIGPMK-UHFFFAOYSA-N 0.000 claims 3
- MAAADQMBQYSOOG-UHFFFAOYSA-N 4-bromo-2-ethylphenol Chemical compound CCC1=CC(Br)=CC=C1O MAAADQMBQYSOOG-UHFFFAOYSA-N 0.000 claims 3
- IWJGMJHAIUBWKT-UHFFFAOYSA-N 4-bromo-2-methylphenol Chemical compound CC1=CC(Br)=CC=C1O IWJGMJHAIUBWKT-UHFFFAOYSA-N 0.000 claims 3
- IBNNFYOOPXNGIL-UHFFFAOYSA-N 4-bromo-2-pentan-2-ylphenol Chemical compound CCCC(C)C1=CC(Br)=CC=C1O IBNNFYOOPXNGIL-UHFFFAOYSA-N 0.000 claims 3
- AEHYMMFSHCSYAA-UHFFFAOYSA-N 4-bromo-2-propylphenol Chemical compound CCCC1=CC(Br)=CC=C1O AEHYMMFSHCSYAA-UHFFFAOYSA-N 0.000 claims 3
- LYOFHYLVYHTGBK-UHFFFAOYSA-N 4-chloro-1,5-dimethylcyclohexa-2,4-dien-1-ol Chemical compound CC1=C(Cl)C=CC(C)(O)C1 LYOFHYLVYHTGBK-UHFFFAOYSA-N 0.000 claims 3
- XRUHXAQEOJDPEG-UHFFFAOYSA-N 4-chloro-2-cyclohexylphenol Chemical compound OC1=CC=C(Cl)C=C1C1CCCCC1 XRUHXAQEOJDPEG-UHFFFAOYSA-N 0.000 claims 3
- WBQFGBDPSGGESL-UHFFFAOYSA-N 4-chloro-2-ethyl-3,5-dimethylphenol Chemical compound CCC1=C(C)C(Cl)=C(C)C=C1O WBQFGBDPSGGESL-UHFFFAOYSA-N 0.000 claims 3
- LKPNWNSJHHGYLU-UHFFFAOYSA-N 4-chloro-2-ethyl-3-methyl-6-propan-2-ylphenol Chemical compound CCC1=C(C)C(Cl)=CC(C(C)C)=C1O LKPNWNSJHHGYLU-UHFFFAOYSA-N 0.000 claims 3
- ZSTDEWVWZHPUCW-UHFFFAOYSA-N 4-chloro-2-ethyl-5-methylphenol Chemical compound CCC1=CC(Cl)=C(C)C=C1O ZSTDEWVWZHPUCW-UHFFFAOYSA-N 0.000 claims 3
- QCEDDUSMBLCRNH-UHFFFAOYSA-N 4-chloro-2-ethylphenol Chemical compound CCC1=CC(Cl)=CC=C1O QCEDDUSMBLCRNH-UHFFFAOYSA-N 0.000 claims 3
- GWVUUFNNGPSKRX-UHFFFAOYSA-N 4-chloro-2-octylphenol Chemical compound CCCCCCCCC1=CC(Cl)=CC=C1O GWVUUFNNGPSKRX-UHFFFAOYSA-N 0.000 claims 3
- GLXDMSOEJKXENG-UHFFFAOYSA-N 4-chloro-2-propylphenol Chemical compound CCCC1=CC(Cl)=CC=C1O GLXDMSOEJKXENG-UHFFFAOYSA-N 0.000 claims 3
- HFHNPIHVXJLWNW-UHFFFAOYSA-N 4-chloro-3,5-dimethyl-2-pentan-2-ylphenol Chemical compound CCCC(C)C1=C(C)C(Cl)=C(C)C=C1O HFHNPIHVXJLWNW-UHFFFAOYSA-N 0.000 claims 3
- JPQXQTCNMSTQQH-UHFFFAOYSA-N 4-chloro-5-methyl-2-octan-2-ylphenol Chemical compound CCCCCCC(C)C1=CC(Cl)=C(C)C=C1O JPQXQTCNMSTQQH-UHFFFAOYSA-N 0.000 claims 3
- KFZXVMNBUMVKLN-UHFFFAOYSA-N 4-chloro-5-methyl-2-propan-2-ylphenol Chemical compound CC(C)C1=CC(Cl)=C(C)C=C1O KFZXVMNBUMVKLN-UHFFFAOYSA-N 0.000 claims 3
- PBDKPFIVQQUKMK-UHFFFAOYSA-N 4-chloro-5-methyl-2-propylphenol Chemical compound CCCC1=CC(Cl)=C(C)C=C1O PBDKPFIVQQUKMK-UHFFFAOYSA-N 0.000 claims 3
- CYYZDBDROVLTJU-UHFFFAOYSA-N 4-n-Butylphenol Chemical compound CCCCC1=CC=C(O)C=C1 CYYZDBDROVLTJU-UHFFFAOYSA-N 0.000 claims 3
- CSHZYWUPJWVTMQ-UHFFFAOYSA-N 4-n-Butylresorcinol Chemical compound CCCCC1=CC=C(O)C=C1O CSHZYWUPJWVTMQ-UHFFFAOYSA-N 0.000 claims 3
- SZWBRVPZWJYIHI-UHFFFAOYSA-N 4-n-Hexylphenol Chemical compound CCCCCCC1=CC=C(O)C=C1 SZWBRVPZWJYIHI-UHFFFAOYSA-N 0.000 claims 3
- ZNPSUQQXTRRSBM-UHFFFAOYSA-N 4-n-Pentylphenol Chemical compound CCCCCC1=CC=C(O)C=C1 ZNPSUQQXTRRSBM-UHFFFAOYSA-N 0.000 claims 3
- CKGWFZQGEQJZIL-UHFFFAOYSA-N Amylmetacresol Chemical compound CCCCCC1=CC=C(C)C=C1O CKGWFZQGEQJZIL-UHFFFAOYSA-N 0.000 claims 3
- RRAFCDWBNXTKKO-UHFFFAOYSA-N Eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 claims 3
- RLSSMJSEOOYNOY-UHFFFAOYSA-N M-Cresol Chemical compound CC1=CC=CC(O)=C1 RLSSMJSEOOYNOY-UHFFFAOYSA-N 0.000 claims 3
- 229940106025 PHENYLETHYL RESORCINOL Drugs 0.000 claims 3
- SAEOCANGOMBQSP-UHFFFAOYSA-N diazanium;fluoro-dioxido-oxo-$l^{5}-phosphane Chemical compound [NH4+].[NH4+].[O-]P([O-])(F)=O SAEOCANGOMBQSP-UHFFFAOYSA-N 0.000 claims 3
- FXNRKXSSLJKNGH-UHFFFAOYSA-L dipotassium;fluoro-dioxido-oxo-$l^{5}-phosphane Chemical compound [K+].[K+].[O-]P([O-])(F)=O FXNRKXSSLJKNGH-UHFFFAOYSA-L 0.000 claims 3
- XJWSAJYUBXQQDR-UHFFFAOYSA-M dodecyltrimethylammonium bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)C XJWSAJYUBXQQDR-UHFFFAOYSA-M 0.000 claims 3
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 claims 3
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 claims 3
- 235000010292 orthophenyl phenol Nutrition 0.000 claims 3
- HKHXLHGVIHQKMK-UHFFFAOYSA-N 2-Chloro-m-cresol Chemical compound CC1=CC=CC(O)=C1Cl HKHXLHGVIHQKMK-UHFFFAOYSA-N 0.000 claims 2
- KSDMMSMHJOPTSY-UHFFFAOYSA-N 2-bromo-3-(2-methylbutan-2-yl)phenol Chemical compound CCC(C)(C)C1=CC=CC(O)=C1Br KSDMMSMHJOPTSY-UHFFFAOYSA-N 0.000 claims 2
- UNRRZPJVYQDQPL-UHFFFAOYSA-N 2-chloro-3-ethylphenol Chemical compound CCC1=CC=CC(O)=C1Cl UNRRZPJVYQDQPL-UHFFFAOYSA-N 0.000 claims 2
- KHWKJUTXTSNBKW-UHFFFAOYSA-N 2-chloro-3-propylphenol Chemical compound CCCC1=CC=CC(O)=C1Cl KHWKJUTXTSNBKW-UHFFFAOYSA-N 0.000 claims 2
- CGINIQPUMSCPLD-UHFFFAOYSA-N 4-chloro-2-(2-phenylethyl)phenol Chemical compound OC1=CC=C(Cl)C=C1CCC1=CC=CC=C1 CGINIQPUMSCPLD-UHFFFAOYSA-N 0.000 claims 2
- LAMKHMJVAKQLOO-UHFFFAOYSA-N 4-chloro-2-heptylphenol Chemical compound CCCCCCCC1=CC(Cl)=CC=C1O LAMKHMJVAKQLOO-UHFFFAOYSA-N 0.000 claims 2
- QFVWWVICQQINNI-UHFFFAOYSA-N 4-chloro-3,5-dimethyl-2-propan-2-ylphenol Chemical compound CC(C)C1=C(C)C(Cl)=C(C)C=C1O QFVWWVICQQINNI-UHFFFAOYSA-N 0.000 claims 2
- KNDDEFBFJLKPFE-UHFFFAOYSA-N 4-n-Heptylphenol Chemical compound CCCCCCCC1=CC=C(O)C=C1 KNDDEFBFJLKPFE-UHFFFAOYSA-N 0.000 claims 2
- AJGLCXBDYCEVIE-UHFFFAOYSA-N 5-chloro-3-hydroxy-1H-pyridin-2-one Chemical compound OC1=CC(Cl)=CN=C1O AJGLCXBDYCEVIE-UHFFFAOYSA-N 0.000 claims 2
- MDNWOSOZYLHTCG-UHFFFAOYSA-N Dichlorophene Chemical compound OC1=CC=C(Cl)C=C1CC1=CC(Cl)=CC=C1O MDNWOSOZYLHTCG-UHFFFAOYSA-N 0.000 claims 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N Propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 claims 2
- GEZOYYZDLMSTPU-UHFFFAOYSA-L [Na+].[Ca+2].[O-]P([O-])(F)=O Chemical compound [Na+].[Ca+2].[O-]P([O-])(F)=O GEZOYYZDLMSTPU-UHFFFAOYSA-L 0.000 claims 2
- GORPMJOSUHSODZ-UHFFFAOYSA-N benzene-1,3-diol;2-methylbenzene-1,3-diol Chemical compound OC1=CC=CC(O)=C1.CC1=C(O)C=CC=C1O GORPMJOSUHSODZ-UHFFFAOYSA-N 0.000 claims 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 2
- BJZIJOLEWHWTJO-UHFFFAOYSA-H dipotassium;hexafluorozirconium(2-) Chemical compound [F-].[F-].[F-].[F-].[F-].[F-].[K+].[K+].[Zr+4] BJZIJOLEWHWTJO-UHFFFAOYSA-H 0.000 claims 2
- 125000004494 ethyl ester group Chemical group 0.000 claims 2
- QJLVYSQIYAHNJO-UHFFFAOYSA-L magnesium;fluoro-dioxido-oxo-$l^{5}-phosphane Chemical compound [Mg+2].[O-]P([O-])(F)=O QJLVYSQIYAHNJO-UHFFFAOYSA-L 0.000 claims 2
- NRZWYNLTFLDQQX-UHFFFAOYSA-N p-tert-Amylphenol Chemical compound CCC(C)(C)C1=CC=C(O)C=C1 NRZWYNLTFLDQQX-UHFFFAOYSA-N 0.000 claims 2
- KZKAYEGOIJEWQB-UHFFFAOYSA-N 1,3-dibromopropane;N,N,N',N'-tetramethylhexane-1,6-diamine Chemical compound BrCCCBr.CN(C)CCCCCCN(C)C KZKAYEGOIJEWQB-UHFFFAOYSA-N 0.000 claims 1
- BMVLUGUCGASAAK-UHFFFAOYSA-M 1-hexadecylpyridin-1-ium;fluoride Chemical compound [F-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 BMVLUGUCGASAAK-UHFFFAOYSA-M 0.000 claims 1
- FZLKMKSAXYZVJW-UHFFFAOYSA-N 2-chloro-3-(2-methylbutan-2-yl)phenol Chemical compound CCC(C)(C)C1=CC=CC(O)=C1Cl FZLKMKSAXYZVJW-UHFFFAOYSA-N 0.000 claims 1
- QDZZDFZWNBWUKS-UHFFFAOYSA-N 2-chloro-3-ethylphenol;2-chloro-3-propylphenol Chemical compound CCC1=CC=CC(O)=C1Cl.CCCC1=CC=CC(O)=C1Cl QDZZDFZWNBWUKS-UHFFFAOYSA-N 0.000 claims 1
- FIWYWGLEPWBBQU-UHFFFAOYSA-N 2-heptylphenol Chemical compound CCCCCCCC1=CC=CC=C1O FIWYWGLEPWBBQU-UHFFFAOYSA-N 0.000 claims 1
- ASHGTJPOSUFTGB-UHFFFAOYSA-N 3-methoxyphenol Chemical compound COC1=CC=CC(O)=C1 ASHGTJPOSUFTGB-UHFFFAOYSA-N 0.000 claims 1
- GKCCTCWZNGMJKG-UHFFFAOYSA-N 4-chloro-2-[(5-chloro-2-hydroxyphenyl)methylsulfanylmethyl]phenol Chemical compound OC1=CC=C(Cl)C=C1CSCC1=CC(Cl)=CC=C1O GKCCTCWZNGMJKG-UHFFFAOYSA-N 0.000 claims 1
- UUBASQRIVIRMIQ-UHFFFAOYSA-N 4-chloro-2-hexylphenol Chemical compound CCCCCCC1=CC(Cl)=CC=C1O UUBASQRIVIRMIQ-UHFFFAOYSA-N 0.000 claims 1
- FDFTZPSQIKUAMS-UHFFFAOYSA-N 4-chloro-3-methyl-2-(2-phenylethyl)phenol Chemical compound CC1=C(Cl)C=CC(O)=C1CCC1=CC=CC=C1 FDFTZPSQIKUAMS-UHFFFAOYSA-N 0.000 claims 1
- WXNZTHHGJRFXKQ-UHFFFAOYSA-N 4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1 WXNZTHHGJRFXKQ-UHFFFAOYSA-N 0.000 claims 1
- XFJVXGLBIPWKFE-UHFFFAOYSA-N C(CCCCC)C1=C(C=CC(=C1)Cl)O.C(C)(CCC)C1=C(C=CC(=C1)Cl)O Chemical compound C(CCCCC)C1=C(C=CC(=C1)Cl)O.C(C)(CCC)C1=C(C=CC(=C1)Cl)O XFJVXGLBIPWKFE-UHFFFAOYSA-N 0.000 claims 1
- 239000005977 Ethylene Substances 0.000 claims 1
- REPPNUPKOJKPSP-ZZNWINOMSA-N Niddamycin Chemical compound CO[C@H]1[C@H](O)CC(=O)O[C@H](C)C\C=C\C=C\C(=O)[C@H](C)C[C@H](CC=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](N(C)C)[C@H](O[C@@H]2O[C@@H](C)[C@H](OC(=O)C(C)C)[C@](C)(O)C2)[C@@H](C)O1 REPPNUPKOJKPSP-ZZNWINOMSA-N 0.000 claims 1
- DGFVSJLRCAZVLR-UHFFFAOYSA-M [Cl-].C(C(C)C)C=1C(=C(C([N+](C)(C)CC)(CCOC2=CC=CC=C2)OC2=CC=CC=C2)C=CC=1)CC(C)C Chemical compound [Cl-].C(C(C)C)C=1C(=C(C([N+](C)(C)CC)(CCOC2=CC=CC=C2)OC2=CC=CC=C2)C=CC=1)CC(C)C DGFVSJLRCAZVLR-UHFFFAOYSA-M 0.000 claims 1
- 239000004305 biphenyl Substances 0.000 claims 1
- 229920005549 butyl rubber Polymers 0.000 claims 1
- DWYMPOCYEZONEA-UHFFFAOYSA-L fluoridophosphate Chemical compound [O-]P([O-])(F)=O DWYMPOCYEZONEA-UHFFFAOYSA-L 0.000 claims 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims 1
- 239000011777 magnesium Substances 0.000 claims 1
- 229910052749 magnesium Inorganic materials 0.000 claims 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 150000003568 thioethers Chemical class 0.000 claims 1
- 230000002209 hydrophobic Effects 0.000 abstract description 29
- 230000001580 bacterial Effects 0.000 abstract description 18
- 230000000845 anti-microbial Effects 0.000 abstract description 11
- 230000001681 protective Effects 0.000 abstract description 4
- 241000894006 Bacteria Species 0.000 description 64
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 32
- 239000002904 solvent Substances 0.000 description 21
- 235000010585 Ammi visnaga Nutrition 0.000 description 17
- 240000005093 Ammi visnaga Species 0.000 description 17
- 241000628997 Flos Species 0.000 description 17
- 239000000126 substance Substances 0.000 description 17
- 239000000243 solution Substances 0.000 description 15
- 230000001680 brushing Effects 0.000 description 14
- 238000005259 measurement Methods 0.000 description 14
- 238000000034 method Methods 0.000 description 14
- 238000004140 cleaning Methods 0.000 description 13
- 239000011248 coating agent Substances 0.000 description 12
- 238000000576 coating method Methods 0.000 description 12
- 229920000742 Cotton Polymers 0.000 description 11
- 239000002609 media Substances 0.000 description 11
- 239000003093 cationic surfactant Substances 0.000 description 9
- 238000001035 drying Methods 0.000 description 9
- 229960004867 hexetidine Drugs 0.000 description 9
- 230000002401 inhibitory effect Effects 0.000 description 9
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N Oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 238000009826 distribution Methods 0.000 description 8
- 239000011521 glass Substances 0.000 description 8
- 229910052757 nitrogen Inorganic materials 0.000 description 8
- 239000004094 surface-active agent Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 238000005755 formation reaction Methods 0.000 description 7
- 239000005871 repellent Substances 0.000 description 7
- 239000005662 Paraffin oil Substances 0.000 description 6
- 229940034610 Toothpaste Drugs 0.000 description 6
- KWIUHFFTVRNATP-UHFFFAOYSA-N Trimethylglycine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 6
- 230000001464 adherent Effects 0.000 description 6
- 239000003242 anti bacterial agent Substances 0.000 description 6
- 230000000844 anti-bacterial Effects 0.000 description 6
- 125000004432 carbon atoms Chemical group C* 0.000 description 6
- 239000006185 dispersion Substances 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 231100001004 fissure Toxicity 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- CTQNGGLPUBDAKN-UHFFFAOYSA-N o-xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 6
- 230000002829 reduced Effects 0.000 description 6
- 239000000606 toothpaste Substances 0.000 description 6
- 239000008096 xylene Substances 0.000 description 6
- 210000000214 Mouth Anatomy 0.000 description 5
- 241000194019 Streptococcus mutans Species 0.000 description 5
- 229940031008 Streptococcus mutans Drugs 0.000 description 5
- 150000007513 acids Chemical class 0.000 description 5
- 238000010828 elution Methods 0.000 description 5
- 150000002430 hydrocarbons Chemical class 0.000 description 5
- 239000011528 polyamide (building material) Substances 0.000 description 5
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 239000005642 Oleic acid Substances 0.000 description 4
- 241000193987 Streptococcus sobrinus Species 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 125000003277 amino group Chemical group 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- YCKRFDGAMUMZLT-UHFFFAOYSA-N fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 4
- 230000000813 microbial Effects 0.000 description 4
- 150000002829 nitrogen Chemical group 0.000 description 4
- 229920001778 nylon Polymers 0.000 description 4
- 239000003208 petroleum Substances 0.000 description 4
- 229920001296 polysiloxane Polymers 0.000 description 4
- 230000002940 repellent Effects 0.000 description 4
- 150000003839 salts Chemical group 0.000 description 4
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 3
- KRHYYFGTRYWZRS-UHFFFAOYSA-N HF Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 3
- 101700013802 MCPI Proteins 0.000 description 3
- 101700069522 MCPIB Proteins 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 3
- 210000003296 Saliva Anatomy 0.000 description 3
- 229940027983 antiseptics and disinfectants Quaternary ammonium compounds Drugs 0.000 description 3
- 229960003237 betaine Drugs 0.000 description 3
- 230000003115 biocidal Effects 0.000 description 3
- CPELXLSAUQHCOX-UHFFFAOYSA-M bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 3
- 150000004985 diamines Chemical class 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 125000000623 heterocyclic group Chemical group 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 238000005498 polishing Methods 0.000 description 3
- 229920000867 polyelectrolyte Polymers 0.000 description 3
- 230000002035 prolonged Effects 0.000 description 3
- 239000011253 protective coating Substances 0.000 description 3
- 239000007320 rich medium Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 208000002925 Dental Caries Diseases 0.000 description 2
- 208000002064 Dental Plaque Diseases 0.000 description 2
- 206010072575 Gingival inflammation Diseases 0.000 description 2
- 208000007565 Gingivitis Diseases 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 210000004283 Incisor Anatomy 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N Palmitic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- NXLOLUFNDSBYTP-UHFFFAOYSA-N Retene Chemical compound C1=CC=C2C3=CC=C(C(C)C)C=C3C=CC2=C1C NXLOLUFNDSBYTP-UHFFFAOYSA-N 0.000 description 2
- HKZLPVFGJNLROG-UHFFFAOYSA-M Silver chloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 2
- REYHXKZHIMGNSE-UHFFFAOYSA-M Silver(I) fluoride Chemical compound [F-].[Ag+] REYHXKZHIMGNSE-UHFFFAOYSA-M 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N Stearic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- 208000008312 Tooth Loss Diseases 0.000 description 2
- 238000005296 abrasive Methods 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
- 230000001070 adhesive Effects 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 238000007605 air drying Methods 0.000 description 2
- 230000003110 anti-inflammatory Effects 0.000 description 2
- 230000002421 anti-septic Effects 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 239000007621 bhi medium Substances 0.000 description 2
- 230000001588 bifunctional Effects 0.000 description 2
- 150000004283 biguanides Chemical class 0.000 description 2
- 230000000903 blocking Effects 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 230000001055 chewing Effects 0.000 description 2
- 230000003750 conditioning Effects 0.000 description 2
- 231100000078 corrosive Toxicity 0.000 description 2
- 231100001010 corrosive Toxicity 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 239000000551 dentifrice Substances 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000002657 fibrous material Substances 0.000 description 2
- 229920002313 fluoropolymer Polymers 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000002070 germicidal Effects 0.000 description 2
- FJLUATLTXUNBOT-UHFFFAOYSA-N hexadecan-1-amine Chemical class CCCCCCCCCCCCCCCCN FJLUATLTXUNBOT-UHFFFAOYSA-N 0.000 description 2
- 230000005660 hydrophilic surface Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000018984 mastication Effects 0.000 description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 2
- WTBAHSZERDXKKZ-UHFFFAOYSA-N octadecanoyl chloride Chemical class CCCCCCCCCCCCCCCCCC(Cl)=O WTBAHSZERDXKKZ-UHFFFAOYSA-N 0.000 description 2
- 230000036961 partial Effects 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 239000012169 petroleum derived wax Substances 0.000 description 2
- 235000019381 petroleum wax Nutrition 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 229940096017 silver fluoride Drugs 0.000 description 2
- 238000009987 spinning Methods 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- YXFVVABEGXRONW-UHFFFAOYSA-N toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 2
- XFNJVJPLKCPIBV-UHFFFAOYSA-N 1,3-Diaminopropane Chemical class NCCCN XFNJVJPLKCPIBV-UHFFFAOYSA-N 0.000 description 1
- WDRZVZVXHZNSFG-UHFFFAOYSA-N 1-ethenylpyridin-1-ium Chemical compound C=C[N+]1=CC=CC=C1 WDRZVZVXHZNSFG-UHFFFAOYSA-N 0.000 description 1
- HJNAJKBRYDFICV-UHFFFAOYSA-M 1-tetradecylpyridin-1-ium;bromide Chemical compound [Br-].CCCCCCCCCCCCCC[N+]1=CC=CC=C1 HJNAJKBRYDFICV-UHFFFAOYSA-M 0.000 description 1
- KRZCNRGNPAESDC-UHFFFAOYSA-N 2-[3-[bis(2-hydroxyethyl)amino]propyl-octadecylamino]ethanol Chemical compound CCCCCCCCCCCCCCCCCCN(CCO)CCCN(CCO)CCO KRZCNRGNPAESDC-UHFFFAOYSA-N 0.000 description 1
- QTDCGWKKIXYBSL-UHFFFAOYSA-N 2-hydroxydodecyl-(2-hydroxyethyl)-dimethylazanium Chemical compound CCCCCCCCCCC(O)C[N+](C)(C)CCO QTDCGWKKIXYBSL-UHFFFAOYSA-N 0.000 description 1
- NELGPGQMQVOTKH-UHFFFAOYSA-N 2-methoxy-4-prop-2-enylphenol Chemical compound COC1=CC(CC=C)=CC=C1O.COC1=CC(CC=C)=CC=C1O NELGPGQMQVOTKH-UHFFFAOYSA-N 0.000 description 1
- LFVVNPBBFUSSHL-UHFFFAOYSA-N Alexidine Chemical compound CCCCC(CC)CNC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NCC(CC)CCCC LFVVNPBBFUSSHL-UHFFFAOYSA-N 0.000 description 1
- 229940064005 Antibiotic throat preparations Drugs 0.000 description 1
- 229940083879 Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE Drugs 0.000 description 1
- 229940042052 Antibiotics for systemic use Drugs 0.000 description 1
- 229940042786 Antitubercular Antibiotics Drugs 0.000 description 1
- 206010004017 Bacterial disease carrier Diseases 0.000 description 1
- 210000004556 Brain Anatomy 0.000 description 1
- ABNDJFFCGNSBBB-UHFFFAOYSA-N C(C)(CCC)C1=C(C=C(C(=C1C)Cl)C)O.C(C)(C)C1=CC(=C(C(=C1O)CC)C)Cl Chemical compound C(C)(CCC)C1=C(C=C(C(=C1C)Cl)C)O.C(C)(C)C1=CC(=C(C(=C1O)CC)C)Cl ABNDJFFCGNSBBB-UHFFFAOYSA-N 0.000 description 1
- HIWXOSQJNKGWQC-UHFFFAOYSA-N C(CCC)C1=C(C=CC(=C1)Br)O.C(CC)C1=C(C=CC(=C1)Br)O.C(C)C1=C(C=CC(=C1)Br)O.CC1=C(C=CC(=C1)Br)O.BrC1=CC=C(C=C1)O.C(C)(CCCCCC)C1=CC(=C(C=C1O)C)Cl Chemical compound C(CCC)C1=C(C=CC(=C1)Br)O.C(CC)C1=C(C=CC(=C1)Br)O.C(C)C1=C(C=CC(=C1)Br)O.CC1=C(C=CC(=C1)Br)O.BrC1=CC=C(C=C1)O.C(C)(CCCCCC)C1=CC(=C(C=C1O)C)Cl HIWXOSQJNKGWQC-UHFFFAOYSA-N 0.000 description 1
- CXORBHLQXUIXSB-UHFFFAOYSA-N CC1=CC(Cl)=CC=C1O.CC1=CC(O)=CC=C1Cl.CC1=CC(O)=CC(C)=C1Cl.CC1=CC(O)=C(Cl)C(C)=C1Cl.CC1=C(O)C(Br)=C(Br)C(Br)=C1Br.CCCCCC1=CC=C(C)C=C1O.OC1=CC=CC=C1C1=CC=CC=C1 Chemical compound CC1=CC(Cl)=CC=C1O.CC1=CC(O)=CC=C1Cl.CC1=CC(O)=CC(C)=C1Cl.CC1=CC(O)=C(Cl)C(C)=C1Cl.CC1=C(O)C(Br)=C(Br)C(Br)=C1Br.CCCCCC1=CC=C(C)C=C1O.OC1=CC=CC=C1C1=CC=CC=C1 CXORBHLQXUIXSB-UHFFFAOYSA-N 0.000 description 1
- KFOVPBPWNYIRPZ-UHFFFAOYSA-N CCOC(=O)C1=CC=C(O)C=C1.CCCOC(=O)C1=CC=C(O)C=C1.CCCCOC(=O)C1=CC=C(O)C=C1 Chemical compound CCOC(=O)C1=CC=C(O)C=C1.CCCOC(=O)C1=CC=C(O)C=C1.CCCCOC(=O)C1=CC=C(O)C=C1 KFOVPBPWNYIRPZ-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- WOWHHFRSBJGXCM-UHFFFAOYSA-M Cetrimonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 description 1
- 229960003260 Chlorhexidine Drugs 0.000 description 1
- QFPUFPVOEBFUHZ-UHFFFAOYSA-N ClC1=C(C(=C(O)C=C1)CC1=CC=CC=C1)O.C1(=CC=CC=C1)CCCC1=C(O)C=CC=C1O.C1(=CC=CC=C1)CCC1=C(O)C=CC=C1O.C(C1=CC=CC=C1)C1=C(O)C=CC=C1O.C1(=CC=CC=C1)C1=C(O)C=CC=C1O.C(CCCCCCCC)C1=C(O)C=CC=C1O.C(CCCCCCC)C1=C(O)C=CC=C1O.C(CCCCCC)C1=C(O)C=CC=C1O.C(CCCCC)C1=C(O)C=CC=C1O Chemical compound ClC1=C(C(=C(O)C=C1)CC1=CC=CC=C1)O.C1(=CC=CC=C1)CCCC1=C(O)C=CC=C1O.C1(=CC=CC=C1)CCC1=C(O)C=CC=C1O.C(C1=CC=CC=C1)C1=C(O)C=CC=C1O.C1(=CC=CC=C1)C1=C(O)C=CC=C1O.C(CCCCCCCC)C1=C(O)C=CC=C1O.C(CCCCCCC)C1=C(O)C=CC=C1O.C(CCCCCC)C1=C(O)C=CC=C1O.C(CCCCC)C1=C(O)C=CC=C1O QFPUFPVOEBFUHZ-UHFFFAOYSA-N 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 240000007170 Cocos nucifera Species 0.000 description 1
- 240000005497 Cyamopsis tetragonoloba Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N D-sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 210000003298 Dental Enamel Anatomy 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- USIUVYZYUHIAEV-UHFFFAOYSA-N Diphenyl ether Chemical class C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Exidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- MDQRDWAGHRLBPA-UHFFFAOYSA-N Fluoroamine Chemical class FN MDQRDWAGHRLBPA-UHFFFAOYSA-N 0.000 description 1
- PUPFATUGTIQBQA-UZQPLGKSSA-N Fluorophen Chemical compound C([C@@]1(C)C2=CC(O)=CC=C2C[C@H]2[C@@H]1C)CN2CCC1=CC=C(F)C=C1 PUPFATUGTIQBQA-UZQPLGKSSA-N 0.000 description 1
- 206010018276 Gingival bleeding Diseases 0.000 description 1
- UYTPUPDQBNUYGX-UHFFFAOYSA-N Guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 1
- 229940093922 Gynecological Antibiotics Drugs 0.000 description 1
- 210000003041 Ligaments Anatomy 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H Magnesium phosphate tribasic Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- MCSAJNNLRCFZED-UHFFFAOYSA-N Nitroethane Chemical class CC[N+]([O-])=O MCSAJNNLRCFZED-UHFFFAOYSA-N 0.000 description 1
- 206010033546 Pallor Diseases 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 241000282372 Panthera onca Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- WKEDVNSFRWHDNR-UHFFFAOYSA-N Salicylanilide Chemical class OC1=CC=CC=C1C(=O)NC1=CC=CC=C1 WKEDVNSFRWHDNR-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- CZMRCDWAGMRECN-GDQSFJPYSA-N Sucrose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)[C@@]1(CO)[C@H](O)[C@@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-GDQSFJPYSA-N 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 229940024982 Topical Antifungal Antibiotics Drugs 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K Tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 210000002268 Wool Anatomy 0.000 description 1
- STRXAPAZDPHVMV-UHFFFAOYSA-M [Br-].CCCCCCCCCCCCCN(C)C Chemical compound [Br-].CCCCCCCCCCCCCN(C)C STRXAPAZDPHVMV-UHFFFAOYSA-M 0.000 description 1
- AOQKJSMDXZEAIF-UHFFFAOYSA-M [Cl-].C(C(C)C)C1=C(C([N+](C)(C)CC)(CCOCCOC2=CC=CC=C2)CC(C)C)C=CC=C1 Chemical compound [Cl-].C(C(C)C)C1=C(C([N+](C)(C)CC)(CCOCCOC2=CC=CC=C2)CC(C)C)C=CC=C1 AOQKJSMDXZEAIF-UHFFFAOYSA-M 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 239000003082 abrasive agent Substances 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 238000009632 agar plate Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229950010221 alexidine Drugs 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 150000003973 alkyl amines Chemical group 0.000 description 1
- 125000005376 alkyl siloxane group Chemical group 0.000 description 1
- 230000002152 alkylating Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000000675 anti-caries Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000002882 anti-plaque Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- JBIROUFYLSSYDX-UHFFFAOYSA-M benzyl-dodecyl-dimethylazanium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 JBIROUFYLSSYDX-UHFFFAOYSA-M 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 238000009954 braiding Methods 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000005712 crystallization Effects 0.000 description 1
- 230000001066 destructive Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 230000001627 detrimental Effects 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- GQOKIYDTHHZSCJ-UHFFFAOYSA-M dimethyl-bis(prop-2-enyl)azanium;chloride Chemical compound [Cl-].C=CC[N+](C)(C)CC=C GQOKIYDTHHZSCJ-UHFFFAOYSA-M 0.000 description 1
- ROSDSFDQCJNGOL-UHFFFAOYSA-O dimethylaminium Chemical compound C[NH2+]C ROSDSFDQCJNGOL-UHFFFAOYSA-O 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000003028 elevating Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000789 fastener Substances 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 239000004811 fluoropolymer Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 150000004676 glycans Polymers 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- KMXTYZBQPJXGNK-UHFFFAOYSA-N hexadecan-1-amine;hydron;fluoride Chemical compound F.CCCCCCCCCCCCCCCCN KMXTYZBQPJXGNK-UHFFFAOYSA-N 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000040 hydrogen fluoride Inorganic materials 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 125000005027 hydroxyaryl group Chemical group 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229940079866 intestinal antibiotics Drugs 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 125000003010 ionic group Chemical group 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000000670 limiting Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910001512 metal fluoride Inorganic materials 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- NHWHNTDVBXKGLW-UHFFFAOYSA-N methane;phenol Chemical compound C.OC1=CC=CC=C1.OC1=CC=CC=C1 NHWHNTDVBXKGLW-UHFFFAOYSA-N 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000006011 modification reaction Methods 0.000 description 1
- 239000002052 molecular layer Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 229940005935 ophthalmologic Antibiotics Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000002917 oxazolidines Chemical class 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 201000008838 periodontal disease Diseases 0.000 description 1
- 229940112041 peripherally acting muscle relaxants Other quaternary ammonium compounds in ATC Drugs 0.000 description 1
- 230000000505 pernicious Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000002633 protecting Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 239000002965 rope Substances 0.000 description 1
- 230000001624 sedative Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 239000012056 semi-solid material Substances 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing Effects 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- 210000001519 tissues Anatomy 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 231100000402 unacceptable toxicity Toxicity 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 229920003176 water-insoluble polymer Polymers 0.000 description 1
- 238000009941 weaving Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Abstract
The present invention describes applicators containing cationic active surface agents, hydrophobic barrier forming materials and antimicrobial compounds which, upon application to dental surfaces, form a protective film and which inhibits bacterial
Description
METHODS COMPOSITIONS AND DENTAL DISTRIBUTION SYSTEMS FOR
THE PROTECTION OF THE SURFACES OF THE TEETH
DESCRIPTION OF THE INVENTION The present invention relates to oral hygiene and specifically to methods of treating the oral cavity with a dental distribution system, such as a dental floss or toothpick, with cleaning, conditioning and antimicrobial properties; which are provided to the teeth with an impenetrable barrier of protection. The present invention also relates to compositions and dental delivery systems that have improved cleaning, conditioning, and antimicrobial properties, which provide the teeth with an impenetrable barrier of protection. The present invention also relates to novel cationic surfactants especially suitable for use in the present compositions, methods, and dental delivery systems. The oral care industry and health research communities have for many years sought a way to prohibit the attack, spread, growth or colonization of bacteria on teeth since attached bacteria are the beginning of a pernicious chain of events leading to the formation of plaque resistant homes, calculations, and finally, tooth loss. As people in developed countries live longer, dental care plays a very important role in overall health, and developing countries have come to take into account the importance of oral hygiene. The dental plaques that result when the calogenic bacteria (for example, Streptococcus mutans) join in colonies and form deposits on tooth surfaces. The presence of bacteria and deposits is extremely detrimental to the health of the tooth so, if it is not checked, it can result in infected gingival tissue, the formation of dental caries and possible periodontal diseases. In extreme cases its presence can still result in the loss of teeth. Many attempts have been made to control or prevent both the presence of dental caries and the formation of dental plaque. For example, fluoride solutions or gels have been used. Treatment with these materials is typically performed in a dental office periodically, but not at frequent intervals. Such treatments are primarily intended to improve the enamel of the tooth to make it more resistant to the acid action caused by the plaque. Not doing this, however, results in a plaque control for an extended period as the plaque re-establishes itself on the tooth rapidly after ingestion of food. Even when the frequency of application of such solutions and gels increases, only the partial control has been shown. For example, studies in which a solution containing fluoride (a fluoride concentration of 1%) has been applied 4 to 5 times over the course of a year demonstrate that this technique has only limited success due to the rapid re-establishment of the plaque in the oral cavity. Moreover, the daily application of a fluoride gel by means of a mounting polyvinyl tooth for sale for a period of twenty-one months, also does not show a substantial change in plaque formation between treated and untreated patients (see "Clinical Anticaries Effect of A Repeated Sodium Fluoride Application by Mouthpiece," Journal of the American Dental Association, vol 75, No. 3, September, 1967, pages 638-644. Proper use of dental floss is necessary to clean the area Considerable amount of interproximal tooth surfaces, which can not be reached by the bristles of a toothbrush The purpose of using dental floss is: 1. To dislodge and remove any decomposing food material that has accumulated on the surfaces. interproximal that can not be removed by brushing; and 2. dislodge and remove as much as possible the growth of bacterial material (plaque) on the teeth or the superimposed calculations that have been accumulated since the previous cleaning. The concept of using dental floss to clean interproximal spaces seems to have been introduced by Parmly in 1819 ("Practical Guide to the Management of the Theeth," Collins &Croft, Philadelphia, PA). Parmly has suggested the use of waxed silk to clean the teeth of people subject to gingival inflammation. Numerous types of silks have been developed and used for cleaning, until finally in 1948 Bass establishes the optimal characteristics of dental floss (Dental items of Interest, vol.70, pp. 921-34, (1948)). Most of the silks sold at least currently are also "waxed" to help penetration to the interproximal regions; as the "rope" effect described by Bass makes the wax packing difficult to force between the close spaces of the teeth. From 1960 to 1962, numerous clinical studies reported that there is no clinical difference between plaque removal and gingivitis records between waxed and unwaxed dental flosses. In 1970 O'Leary and Hill et al. in 1973 they found no difference in the interproximal cleaning properties of waxed or unwaxed dental floss. This was later reconfirmed in 1982 by Lobene et al. (Clinical Preventative Dentistry, January-February (1982)) who demonstrated that there is no significant clinical difference in plaque and gingivitis records. Similar results, ie, no clinical difference between waxed and unwaxed silks with respect to reduced gingival inflammation are shown by Finkelstein in 1979 (J. Dent, Res .. vol 58, pp 1034-1039 (1979)). No difference is shown in gingival health by Wunderlich in 1981 (J. Dent. Res .. vol 60A, p.862 (1981)). No difference in plaque removal is reported by Schmidt et al. in 1962 (J. Dent. Res .. (1962)) with silks of various types. Stevens in 1980, studied silk with variable diameters and showed no difference in plaque and gingival health. Cárter et al., Va Dent. J .. vol 52, pp. 18-27
(1975), studied waxed and unwaxed silks administered professionally and by himself and found that both significantly reduce gingival bleeding of interproximal and gingival sulci. Non-waxed silk seems to be slightly, but not significantly more effective. In view of these clinical work, it is not surprising that most of the dental flosses sold today are tied and / or waxed. The "ligament" in the weaving industry today is used more to facilitate the process and production during the manufacture of silk and packaging than for reasons of "sedatives". Since clinical trials show no difference between waxed and unwaxed silks, the silk industry has been quiet with the trend of the fabric industry to employ silk-binding agents. In any event, most people in the world do not use silk on their teeth. Instead, toothpicks or toothpicks are often used to clean your teeth. Maetani et al, in U.S. Patent No. 2,504,228 discloses a metal dental moldable coating with a PTFE coating. The PTFE coating is applied from a solution. The PTFE can also be applied to a suspension (an organosol) which can include other resins as well, such as, for example, a silicone. Lorch, in U.S. Patent No. 4,776,358 describes a silk ribbon that carries its own supply of a toothpaste. The tape can be made from a confronting pair of laminated films that are microporous. The toothpaste is placed between the confronted surfaces of the two sheets and the opposite longitudinal edges of the two sheets are sealed together. In the use of toothpaste it flows out through the pores of the sheets. The sheets can be PTFE films. The toothpaste is a conventional material, usually a commercially available material.
Blass, in the United States Patent No ~. No. 4,996,056 describes the coating of a silk or dental tape with a mixture of wax and a PTFE powder. La Rochelle, in U.S. Patent No. 4,157,386 discloses a tablet which covers the surfaces of the teeth and which contains fluoride ion, a polishing agent, and a vegetable oil. Gaffar et al, in U.S. Patent No. 5,344,641 discloses a toothpaste containing an antibacterial agent, an improved antibacterial agent, a polishing agent and a solubilizing agent. The improved antibacterial agent is a material that forms an anionic film that is thought to bond to the surface of the tooth thereby preventing bacterial attack and elevating the supply of antibacterial agent to tooth surfaces. Raaf et al, in U.S. Patent No. 4,169,885 discloses a filled capsule which has an outer hydrophilic active substance and an inner core containing a hydrophobic substance, a fluoride source and an antimicrobial substance. On the consumption of the capsule, the hydrophilic substance is believed to bind the hydrophobic active substance to the teeth. Hill et al., In the United States Patent
No. 5,165,913 describes dental floss which contains a surfactant, silicone and a chemotherapeutic agent. The therapeutic agent is distributed over the spread of the silk. The surfactant and silicone are believed to cover the teeth, providing a uniform sense to the user, and preventing the attack of the bacteria. Chang, in the Reissued State Patent
United No, 31,787 describes a toothpaste that reduces elution that contains a material that forms a membrane. The application of the membrane-forming material is believed to inhibit the elution of a previously applied therapeutic agent, (i.e., fluoride). Curtis et al., In U.S. Patent No. 4,528,182 and Crawford et al., In U.S. Patent No. 4No. 490,353 disclose an antiplaque dentifrice composition containing a quaternary ammonium compound, a betaine surfactant, polyethylene glycol and an abrasive. The presence of the betaine surfactant is believed to increase the dentifrice foam and prevent the deactivation of the quaternary ammonium compound. However, none of these methods have proven to be satisfactory. In this way, there remains a definite need in the art to improve methods, compositions and dental distribution systems which are effective for the prevention of bacterial adhesion to teeth and exhibit antimicrobial properties.
There also remains a need for compositions which can be effectively applied to the teeth using a toothpick or dental bars and which result in improved antimicrobial properties. Accordingly, it is an object of the present invention to provide a novel dental delivery system which exhibits improved antimicrobial properties. It is another object of the present invention to provide novel dental flosses which exhibit improved antimicrobial properties. It is another object of the present invention to provide novel toothpicks which exhibit improved antimicrobial properties. It is another object of the present invention to provide a method for treating teeth, which confers improved microbial resistance on the teeth. It is another object of the present invention to provide a method for treating teeth, which confers prolonged microbial resistance on the teeth. It is another object of the present invention to provide a method for treating teeth which results in a reduced ability of the bacteria to adhere to the teeth.
It is another object of the present invention to provide novel compositions which impart improved microbial resistance to teeth. It is another object of the present invention to provide novel compositions, which confer prolonged microbial resistance to the teeth. It is another object of the present invention to provide novel compositions, which result in a reduced ability of the bacteria to adhere to the tooth. It is another object of the present invention to provide novel cationic surfactants useful in such methods, compositions, and dental delivery systems. It is another object of the present invention to treat / cover dental surfaces with a hardened, inert, continuous, hydrophobic material, which constitutes a physical barrier against access to the tooth surface of bacteria, acids, remnant foods, etc .; and prevent the loss of fluoride by elution of dental surfaces. It is another object of the present. invention provide such barriers, by deposition on dental surfaces, which include materials, which can improve the purposes of oral hygiene such as fluoride sources, substances which show inhibit the attack, spread, growth or colonization of undesirable bacteria, Antiseptic or antibiotic materials, detergents, anti-inflammatories and other active agents. These and other objects, which will be more apparent during the following detailed description, have been achieved by the discovery of the inventors of the application of a composition which comprises: (a) from 1 to 20% by weight, based on the total weight of (a) and (b) of a transfer agent; and (b) from 80 to 99% by weight, based on the total weight of (a) and (b) of a barrier material for the teeth resulting in a prolonged reduction in the ability of the bacteria to adhere to the teeth. In this way, the present invention provides new compositions which are attached to substrates, especially those dental surfaces (teeth), which have pits, fissures, depressions, fractures, dental tubules, interstices or irregularities. The compositions according to the topography of the surfaces of the teeth, which deposit protective barrier materials on the surfaces of the teeth. The methods of this invention result in the attachment of waxy materials to substrates, such as teeth. The application of the present compositions to dental floss or dental tape, according to the methods of the present invention, provides an appropriate combination of bonding to silk or tape together with the transferability of the compositions on and towards the surfaces of the teeth. during the use of the tape or silk. The compositions of the present invention can be applied to tooth surfaces using toothbrushes, both manual and automated, which have both "natural" bristles or nylon or other fibers, multifilaments or monofilaments. The methodology used to apply the barrier materials and the duplex films to the bristles can be as described below as it is used for the application to silks and dental tapes. The compositions of the present invention can also be applied to dental surfaces using any variety of interdental or dental devices of wood, plastic, metals, etc. A device similar to a bar may be covered at one or both ends with any material suitable for coating with the composition of the present invention. The device may be similar to the interdental devices presented in the market by Johnson & amp;; Johnson known as "Sti udents", in a configuration similar to the popular cotton Q-Tips, or in the configuration in which the applicator is inserted into or otherwise attached to an appropriate fastener. The materials used to cover the ends of the device applicator may include, for example: a) natural or synthetic yarns, filaments, or other fibrous materials as well as those assembled as textiles, or for any cord material, braiding, spinning, not spinning , woven, caked, flocked, etc., in which the materials of the composition of the present invention (referred to herein as MCPI) are held between the fibers or braids of the materials; b) porous or foam-like materials in which the MCPI is held between the pores or openings; or c) non-porous, non-fibrous materials such as some types of wool, plastic, metal, etc. In the following examples, the surfaces of wooden toothpicks are coated and an MCPI film transferred to the wet surfaces of microscopic glass guides. The toothpicks are merely submerged and dried, using the same techniques as for dental floss. Thus, in one embodiment of the present invention, the surfaces of the teeth are coated with a material which forms a "duplex film" composed of a monolayer of electrostatically very strong adhesive of a positively charged polyolelectrolyte (such as, for example, , polyethyleneimine, PEI) reacted with a monolayer of fatty acid molecules. The fatty acid molecules bind to the PEI layers with their carboxylic groups while the hydrocarbon portions of the fatty acid chains form a highly hydrophobic interface that is compatible with the hydrophobic barrier materials. In addition to the fatty acids, other compounds having low surface tension and water repellent properties that can be employed in the practice of the present invention include polymethylalkysiloxanes such as, for example, polymethylhexadecylsiloxane, and polyfluoroalkylmethylsiloxanes (eg, polymethyl-3). , 3, 3-trifluoropropyl-siloxane). This additionally increases the hydrophobicity of the duplex films and facilitates the transfer of the hydrophobic barrier materials. Saturated hydrocarbons such as waxes, which include beeswax, carnauba wax and petroleum waxes such as paraffins, and fluorocarbon polymers can also be employed. In other applications, the duplex film can be replaced by a single monolayer composed of a low molecular weight surfactant in which positively charged groups react with the surfaces of the teeth and the water repellent portions of the chain form a highly hydrophobic interface. Examples of such surfactants are cetyltrimethylammonium bromide (C ) hexadecyltrimethylammonium bromide (HD ) and various amines and quaternary amines, of which a good example is the quaternary amine Hyamine-1622. The compositions of the present invention are materials generally in the solid or semi-solid state which can be applied to dental surfaces by dental floss, dental tape, interdental devices, cotton swabs, bars, toothpicks and other applicators or methods of application by the dentist. which solid or semi-solid materials can be brought into contact with tooth surfaces. Such applicators or methods of application are mentioned later referred to as "Applicators". As shown in the schematic illustrations given in Figures 1 and 2a and b, the compositions of the present invention, as applied to dental surfaces, provide a multi-stratus protective coating (hereinafter referred to as "protective coating: or "PC"), as follows: (1) The layer of the transfer agent that has double functionality, is composed of materials that have some molecular segments or parts of a polymer chain which is positively charged and other segments which exhibit characteristics hydrophobic
Three categories of transfer agent materials include: (a) monomeric cationic surfactants, (b) cationic polyelectrolytes or their products or complexes with organic or inorganic acids, and (c) polypeptide-like materials that have a preponderance of positively charged functional groups. . (2) The barrier layer: for the hydrophobic components of the transfer agent layer, a hydrophobic, inert material (hereinafter referred to as a "barrier" material), such as a wax adheres. The thickness of the barrier layer is typically between lμ and approximately 10μ. In the preferred embodiments of PC they may additionally provide: (3) The antibacterial function: Within the barrier layer, therapeutically, hygienically or otherwise desirable materials may be mixed which are released as soon as they are exposed on the surfaces of the barrier layer. One of the materials typically mixed in the barrier material is a substance or substances that show inhibit attack or otherwise stop the spread, growth or colonization of harmful bacteria such as Streptococcus mutans, S. sobrinus, etc. As indicated above the composition may additionally comprise other active agents. Such substance will be referred to hereinafter as "Active Agent" or "A-A" material. In this way, the present invention makes possible the first significant improvement in consumption or dental care in the home in decades. Specifically, the present invention provides the following advances: I. The application of a composition of the present invention to the teeth provides a continuous, hydrophobic, inert barrier which prevents acids, corrosive materials, (Figure 9 shows various corrosive materials on a surface not treated on the left side, 9a compared to the same materials on the surface treated with a composition of the present invention on the right side, 9b), food particles, bacteria and other materials that gain access to the treated dental surface and thus provide protection against all the usual destructive processes - including the loss of fluoride by elution. In addition, these harmful substances do not easily attack the barrier as they would to the surface of the unprotected tooth. II. Any bacteria or other residue which attacks the protective barrier is easily removed by brushing teeth, cleaning with water pressure, silks and even, probably by rigorous mouth rinsing as the amorphous barrier is easily penetrated or cut, removing the more exterior material but removing something from its remaining protection barrier. Without such protection, the bacteria which have attacked by themselves to the surface of the tooth soon become impossible to dislodge by brushing teeth or with silks and must be professionally removed. Since the bacterial attack begins to take place after each meal, the barrier is of greater prophylactic significance. III. The barrier material easily fills and thus seals holes, fissures and fractures, which are the favorite competition for bacterial colonization and plaque development. The barrier remains in place until it is mechanically removed from these holes, etc. and therefore provides protection which is still more widespread in vulnerable areas, since the barrier material is not removed from holes, cracks, etc. As easily as from the surface of uniform teeth in the ordinary course of abrasive action by the tongue, food chewing, brushing of teeth, etc. IV. By the addition to the barrier composition of an antibacterial material, 5-amino-1, 3-bis (2-ethylhexyl) -5-methylhexahydropyrimidine, which is obtained from Angus Chemical Co, under the trade name of Hexetidine, being a example of a more especially preferred active agent, bacterial attack on the barrier surface is reduced by an estimated 90% or more, compared to the number of bacteria density which attack the surface of unprotected teeth. Of course, these bacteria which make the attack, are easily removed by the typical customary activities such as brushing teeth and silk. In addition, hexetidine appears to migrate or diffuse from the barrier material to the tooth surface to which the barrier does not reach, providing some protection to these more vulnerable areas that are difficult to reach. V. Of importance, the benefits of the present invention can be provided by a wide range of application methods, for example, silk and dental tape, Q'tips®-like cotton swabs, toothpicks, interdental devices such as Stimudents®, toothbrushes, pre-coated teeth, and any other applicators for usual or professional jobs that one wishes to use. The only criterion is that it must be able to contact a wax material to the tooth surfaces. In this way, the application of the present compositions is effective to treat / coat dental surfaces with a hard, inert, continuous, hydrophobic composition which constitutes a physical barrier against access to the tooth surface by bacteria, acids, remnant foods , etc., and prevents the loss of fluoride by elution of dental surfaces. In addition, the attack of bacteria is significantly reduced by the barrier, than the attack on unprotected tooth surfaces. More importantly, the bacteria and other materials which attack the barrier are easily removed by brushing teeth, flossing, cleaning with water pressure and even vigorous mouth rinsing since the amorphous barrier material is easily penetrated or cut with a small effort. Even after the removal of such surface materials, the barrier materials remain to continue the protection provided. One application and one subsequent, the barrier materials of the present invention are forced to conform the topography of the dental surfaces in which they will be applied. Especially important, barrier materials fill holes, fissures, fractures and other imperfections in dental surfaces, thus blocking those sites in which bacteria are most frequently found and from which it is more difficult to remove. And at such sites, barrier materials are less subject to removal by the usual oral sources of abrasion and surface activities such as tongue movements, tooth brushing, chewing, etc., and thus provide the most hardened protection where is needed In a preferred embodiment, the barrier material includes agents which improve the purposes of oral hygiene such as substances which are: (a) shown to elevate the inhibition of attack, propagation, growth or colonization of undesirable bacteria, (b) other germicidal, antiseptic or antibiotic materials, (c) anti-inflammatory and (d) other desirable agents. Using one of the preferred embodiments of the present invention, in which a material derived from heterocyclic nitroparaffins, such as hexetidine, is mixed in the barrier composition, the bacterial attack on the protected barrier is reduced by = 90% as compared to the surfaces of unprotected tooth. These few bacteria which can attack the barrier surface are removable with a gentle cutting action. BRIEF DESCRIPTION OF THE DRAWINGS A more complete appreciation of the invention and many of the concomitant advantages thereof will be readily obtained as soon as it becomes understood with reference to the following detailed description when considered together with the accompanying drawings., where :
Figure 1 is a partial section, taken in a horizontal e, through a human tooth, coated, showing the surface of the irregular tooth, the conformation of the coating to the surface of the tooth and its relative thickness, all in one enlarged scale. The hydrophobic barrier film, which contains the antibacterial and other functional agents, which forms the substrate and fills the pits, fissures, fractures and other irregularities of the tooth surface. The transfer layer facilitates adhesion of the hydrophobic barrier film to the surface of the tooth; Figures 2a and b are enlarged views of the surface of the coated tooth, showing the area of the tooth surface in Figure 1, to demonstrate the distribution of electrostatic charges at the interface between the tooth surface and the transfer agent. These figures illustrate the mode of attachment of the transfer agent to the surface of the negatively charged tooth, (a) The molecules of the positively charged surfactant form a dense monolayer which binds to the negatively charged substrate. The alkyl groups of the transfer agent face away from the surface. The hydrophobic barrier film, which contains the antibacterial and other functional agents, that make up the substrate and fill the pits, fissures, fractures and other irregularities of the tooth surface. The transfer layer facilitates adhesion of the barrier film - hydrophobic to the surface of the tooth; Figures 2a and b are elongated views of the surface of the coated tooth, showing the area of the tooth surface in Figure 1, to demonstrate the distribution of electrostatic charges at the interface between the tooth surface and the transfer agent. These figures illustrate the mode of attachment of the transfer agent. to the tooth surface negatively charged. (a) The positively charged surfactant molecules form a dense monolayer which binds to the negatively charged substrate. The alkyl groups of the transfer agent face away from the surface, (b) The polyamine molecules absorbed into the substrate with their hydrophobic side groups facing away from the hydrophilic surface of the tooth; Figure 3 shows the application of a composition according to the present invention to a tooth by a cotton swab; Figures 4a and b are photomicrographs of an untreated tooth (Figure 4a) and a tooth treated according to the present invention (Figure 4b) after exposure to the bacteria-rich medium for 48 hours;
Figure 5 shows the application of a composition according to the present invention to a tooth by a toothbrush; Figures 6a and b are photomicrographs of an untreated tooth (Figure 6a) and a tooth treated according to the present invention (Figure 6b) after exposure to the bacteria-rich medium for 48 hours; Figure 7 shows the application of a composition according to the present invention to a tooth by a dental floss; Figures 8a and b are photomicrographs of an untreated tooth (Figure 8a) and a tooth treated according to the present invention (Figure 8b) after exposure to the bacteria rich medium for 48 hours; and Figures 9a and b show the appearance of staining materials in an untreated glass guide (Figure 9a) and a treated guide according to the present invention (Figure 9b). Thus, in a first embodiment, the present invention provides novel compositions which contain: (a) 1 to 20% by weight, based on the total weight of (a) and (b), of a transfer agent; and (b) 80 to 90% by weight, based on the total weight of (a) and (b), of a barrier material.
Preferably, the present composition contains: (a) 3 to 5% by weight, based on the total weight of (a) and (b), of a transfer agent; and (b) 95 to 97% by weight, based on the total weight of (a) and (b), of a barrier material. THE FUNCTION OF THE TRANSFER AGENT To adhere a hydrophobic barrier material to the wet, hydrophilic, negatively charged surface of the tooth, a bifunctional transfer agent material is employed. This material has some active groups which are positively charged electrostatically and are active groups which are compatible with the hydrophobic materials of the barrier layer. Useful transfer agent materials include various compounds of cetylamines, various diamines (including, for example, Duomeens and Ethoduomeens), heterocyclic amines derived from nitroparaffins, and quaternary ammonium compounds. Also useful are the compounds of certain cationic polyelectrolytes, invented for the purposes of the present invention and introduced herein, including for example, polyethylene imine (PEI) derivatized with varying concentrations of fatty acids such as, for example, stearic acid, palmitic acid , oleic acid, etc.
Certain of these transfer agents also inhibit the attack, otherwise stop the propagation, growth or colonization of bacteria such as, for example, Streptococcus mutans and Streptococcus sobrinus, when added in appropriate concentrations to be able to function as an agent transfer and also execute the AA function. Some substances, notably some bifunctional amine hydrofluorides and specifically the quaternary ammonium fluorides, have been employed in the prior art to produce a monolayer or bipolar material that adheres to dental surfaces as well as at the end thereof. But experimentation suggests that the resulting individual molecular layer is insufficient to provide a durable functional barrier against bacterial attack or to prevent access to the tooth surface by acids, etc. Transfer Agent Materials: The cationic transfer agent materials useful in the present invention are believed to bind to the surface of the tooth by a complex interaction between the cationic portion of the material and the protein portion of the tooth and of the tooth. The shape predisposes or conditions the surface of the tooth in such a way that a waxed material will then adhere to the surface. The surface active materials which are capable of binding strongly to negatively charged and hydrophilic surfaces of human teeth include various compounds alkylammonium branched, cyclic alkylammonium compounds, petroleum derived cationic materials, and polymeric cationic materials. a) The branched-chain aquilamonium compounds R '* R "R' R-N 1 -R» R-N + -H X "R-N i + -R" X "I I R" R "'
R represents a long alkyl chain (CQ.Q), which can be substituted with one or more hydroxy groups, R ', R "and R"' each independently can be both a long alkyl chain (Cg_2o) which it can be substituted with one or more hydroxy groups or small alkyl groups (C? _4), which can be substituted with one or more hydroxy groups or aryl groups (Cg_10)? hydrogen, and X "represents an anion such as chlorine or These schematic formulas are given for the purposes of defining the classes of compounds and represent the simplest concepts of cation transfer agents in which one or more hydrophobic alkyl groups are attached to the nitrogen atom.In many cases the bond is more complex , as for example, in RCONHC ^ C ^ C ^ NtC ^) 2 • In addition, the cationic transfer agents may contain more than one cationic nitrogen atom such as the following classes of compounds RNHCH2CH2CH2NH2 and derivatives of the Representative examples of compounds according to the above formulas are: cetyltrimethylammonium chloride (C ), hexadecyltrimethylammonium bromide (HD ), stearyldimethylbenzylammonium chloride, lauryldimethylbenzylammonium chloride, cetyldimethylethylammonium halide, cetyldimethylbenzylammonium halide, cetyltrimethylammonium halide, halide of dodeciletildimetilamonio halide, lauryl trimethylammonium halide cocoalquiltrimetilamonio halide, N, N-Cg_2A-dialkyl, and specifically compounds such as bis (hydrogenated seboso alkyl) dimethylammonium which is known to be absorbed on the surface with hydrophobic groups oriented away it chloride, 2-hydroxydodecyl-2-hydroxyethyl-dimethylammonium and dihydrofluoride N-octadecyl-N, N ', N'-tris- (2-hydroxyethyl) -1, 3-diaminopropane. b) Cyclic alkylammonium compounds A more preferred group of the compounds of the present invention which have been found to be applicable include a class of active surface quaternary ammonium compounds in which the nitrogen atom bearing the cationic charge is part of a heterocyclic ring. Suitable compounds, for example, are as follows: laurylpyridinium chloride or bromide, tetradecylpyridinium bromide, halide (chloride, bromide or fluoride) of cetylpyridinium. c) Petroleum-derived cationics Typical basic amines are derived from petroleum-based raw materials, such as olefins, paraffins, and aromatic hydrocarbons and include compounds with at least one aliphatic carbon chain containing six or more carbon atoms. attached to hydrogen. In this way, the salts amines, diamines, amidoamines, alkoxylated amines and their respective quaternary salts are applicable. Preferred compounds of this type include coconut or substituted sebaceous alkyls of 1,3-propylenediamines sold by Witco under the tradename of "Adogen" and "Emcol" and similar diamines sold by Akzo under the trade name "Duomeen" and its derivatives polyethenoxy under the trade names of "Ethomeen" and
"Ethoduomeens". d) Polymer Amines Suitable polymer amines comprise a class of polymers that contain ionic groups along the main chain and exhibit properties of both electrolytes and polymers. These materials contain nitrogen, of primary, secondary, tertiary or quaternary functionality, in their main column and can have an average weight of molecular weights as low as approximately 100 or as high as approximately 100,000. Representations of these cationic, polymeric transfer agents are the following: polydimeryl polyamine (General Mills Chemical Co.), polyamide (trade name "Versamide"), polyacrylamides, polydiallyldimethylammonium chloride ("Cat-Floc"), polyhexamethylene biguanide compounds under the tradename "Vantocil", and also other biguanides, for example those described in U.S. Patent Nos. 2,684,924, 2,990,425, 3,183,230, 3,468,898, 4,022,834, 4,053,636 and 4,198,425, 1,5-dimethyl-1-polymethyl bromide , 5-diazaundecamethylene ("Polybrene" from Aldrich), polyvinylpyrrolidone and its derivatives, polypeptides, poly (allylamine) hydrochloride, polyoxyethylene amines and specifically polyethyleneimine ("Polymin" from BASF), and a class of related and cationic active surface polymers prepared by converting a fraction of the amino groups to their acyl derivatives. The polyethyleneimine is first condensed with less than the stoichiometric amount of the acid halides in this way by alkylating some of the amino groups and the remaining amino groups are then condensed with hydrogen halides such as hydrogen chloride or, preferably, hydrogen fluoride. The surface activity of these compounds varies with the number of amino groups which are acylated, and with the chain length of the RCO- acylating group. The condensation reaction is typically carried out with oleic or stearic acid chlorides in the presence of a solvent containing metal fluoride, preferably silver fluoride, such that the silver chloride formed in the reaction precipitates from the solvent ( see Example XV). Also suitable, for the purpose of the invention, cationic derivatives of polysaccharides such as dextran, starch or cellulose, for example, diethylaminoethyl cellulose ("DEAE-cellulose"). Examples of applicable copolymers based on acrylamide and a cationic monomer are commercially available under the tradename RETEN from Hercules Inc., or under the name of FLOC AID from National Adhesives. Particular examples of such polymers are FLOC AID 305 and RETEN 220. Similarly useful.
are polyelectrolytes based on acrylamine as sold by Allied Colloids under the name PERCOL. Further examples of suitable materials are cationic guar derivatives such as those sold under the tradename JAGUAR by Celanese-Hall. A further preferred group of compounds which comprise a class of water insoluble polymers, which have nitrogen atoms in their molecules, are quaternary quaternary ammonium type, betaine type, pyridylpyridinium type or vinylpyridinium type polymers. Examples are as follows: poly (vinylbenzylmethylamylammonium chloride), poly (vinylbenzyltearylbetaine), poly (vinylbenzylurilpyridylpyridinium chloride), poly (vinylbenzylcetylammonylhexyl ester) and quaternized polyhoxyethylenated long chain amines with the formula general RN (CH3) [(C4H40)? H] 2 (+) A (-), where A (-) is generally chlorine or fluorine, x is a number from 1 to 20 and R is Cg_22 alkyl- These cationic materials , reacting with dental surfaces, produce strongly hydrophobic films in which hydrophobic barrier materials are easily transferred by spreading, rubbing or polishing.
It is important that the reason for this transferability be understood. The surfaces of human teeth are normally hydrophilic, negatively charged, and are "lubricated" by a hydrated biological film composed of bacteria and other biological organisms. The transfer and adhesion of the barrier materials on such dental surfaces is difficult or practically impossible unless the biological film is modified by a material that is hydrophobic and therefore compatible with the barrier materials. In a preferred embodiment, the transfer agent, a cationic surfactant, is a polymer which contains a nitrogen atom in a repeating unit and in which a portion of the nitrogen atoms are quaternized by formation of a salt with a fatty acid of Cg_2Q 'preferably a C12_2Q fatty acid. Examples of such polymeric cationic surfactants include polyacrylamides, polyvinylpyridines, or polyamines, for example, poly (ethyleneimine), in which from 5 to 95% mol, preferably 40% 60% per mole of nitrogen atoms that have been quaternized by the formation of a salt with a fatty acid. Typically such polymers will have an average molecular weight weight of 600 to 60,000, preferably 600 to 1,800.
In a particularly preferred embodiment, the cationic surfactant is a polymer which contains a nitrogen atom in a repeating unit and in which a first portion of the nitrogen atoms are quaternized with a Cg_2o fatty acid, preferably a fatty acid of C12_20 'and a third (3rd portion of the nitrogen atoms are quaternized to form a salt with HF. Examples of such polymeric cationic surfactants include polyacrylamides, polyvinylpyridines or polyamines, for example, poly (ethylene imine), in which from 5 to 95 % by mole, preferably from 40 to 60% by mole, of the nitrogen atoms are converted to their acid derivatives by reaction with oleic or stearic acid chlorides, and from 5 to 95% by mole, preferably from 40 to 60. % per mole of the nitrogen atoms quaternized with HF In this case, the polymeric cationic surfactant will have an average molecular weight of 600 to 60,000, preferably 600 to 1800. In another preferred embodiment, the cationic surfactant is an alkylamine of Cg_2o which has been quaternized with HF, such as cetylamine hydrofluoride. THE BARRIER FUNCTION Now having a mechanism for adhering a protective, hydrophobic material to the hydrophilic dental substrate, any of the various barrier materials can be selected to perform this function. A microcrystalline wax, for example is a component in a barrier composition which provides an adherent, conformable, hydrophobic, continuous, inert, colorless or with a little color barrier, which is an application and with subsequent rubbing or alteration is forced to the pits, fissures, fractures and other irregularities of the surface of the tooth, thus blocking these most vulnerable sites for occupation by bacteria and other undesirable residues. This wax barrier seems to last in place and function indefinitely or until it is removed mechanically. In this way, with the transfer and barrier functions performed, the extended protection is provided against harmful activities since the treated dental surfaces are entirely sealed against bacteria, acids, staining materials, loss of dental fluoride, etc. In the use, the barrier material is rubbed, in the application and after it, in the holes, fractures, concavities and other depressions. Of importance, the barrier materials are amorphous materials with cut or easily penetrated in such a way that the materials which can adhere to the surface of the barrier can be easily removed by the application of moderate cutting forces such as those applied by the tongue action against dental surfaces, brushing teeth, dental floss, vigorous cleaning of water or vigorous rinsing of the mouth. These same low-cut characteristics move the barrier materials close by exposing any active agent substance mixed in the barrier materials. Hydrophobic Barrier Materials It has been found that several hydrophobic compounds of high molecular weight, solid at body temperature and generally similar to fats and oils are useful as barrier forming materials. Typically they are long chain hydrocarbons, especially normal paraffins having a chain length of 16 carbon atoms or larger, paraffins with various branching sites and unsaturation, where the degree of such branching and unsaturation do not create unacceptable toxicity or low point of solidification below the body temperature, and shows essentially no solubility in water or saliva. The major types of these wax-like materials fall into two basic categories: I. Natural waxes of animal, vegetable or mineral origin, such as beeswax, lanolin, sperm, carnauba wax, petroleum waxes including paraffin waxes and microcrystalline petrolatum; and II. Synthetic materials including ethylene polymers such as "Carbowax" polymethylene wax ("Paraflint") and various types of hydrocarbons as obtained by the Fisher-Tropsch synthesis. Other suitable materials include silicone-based polymers such as polymethyl alkylsiloxane, polydimethylsiloxane, poly (perfluoroalkylmethylsiloxane), poly (methyl-3,3,3-trifluoropropylsiloxane), and various aromatic siloxanes (containing phenyl) and are sold by Petrarch, which is now United Chemical. Also useful are various fluoropolymers where some or all of the hydrogens are replaced by fluorine, which include, among others: polytetrafluoroethylene (PTFE); fluorinated polyethylene-propylene (FEP); polyvinylidene fluoride (PVDF); and polyvinyl fluoride (PVF). These polymers can be applied to dental devices such as aqueous or non-aqueous dispersions. In another embodiment, the present composition contains: (a ') 1 to 10% by weight, preferably 2 to 5% by weight, based on the total weight of (a1), (b') and (c ') of a transfer agent; (b1) 70 to 98% by weight, preferably 85 to 93% by weight, based on the total weight of (a1), (b ') and (c') of a barrier material; and (c1) 1 to 20% by weight, preferably 5 to 10% by weight, based on the total weight of (a1), (b ') and (c') of an active agent. THE FUNCTION (A-A) OF THE ACTIVE AGENT The experiment with the technology of the present invention demonstrates that some types of materials inhibit or stop the attack and / or propagation, growth or colonization of bacteria on dental surfaces. The bacteria with which the experiments were carried out, Streptococcus mutans, and Streptococcus sobrinus, show to be the majority sources of bacterial plaque colonies and their sequelae. Among the materials which demonstrate performing the A-A function are various cetyl inas, nitroparaffin derivatives, duomeens, ethoxylated duomeens, and other quaternary ammonium compounds. Especially useful is 5-amino-1,3-bis (2-ethylhexyl) -5-methylhexahydropyrimidine, such as that obtained from Angus Chemical Co. under the tradename hexetidine. In addition, innovative materials whose benefits and novel compositions are described and claimed for the first time in this description / application are useful as Active Agents. These include polyethyleneimines for which fatty acids such as oleic acid, etc., have been added.Some of the AA materials tested and described in the examples below migrate outward or diffuse away from the areas in which a Protective Coating is applied in such a way that, to some extent, the AA function extends to areas not reached by PC by itself. These materials A-A can be mixed in the barrier material in such a way that, as the barrier material is cut, penetrates, disturbs, erodes, abrades, etc., fresh A-A material is exposed and free to function. Active Agent Materials Various compounds which possess antibacterial activity (i.e., are germicidal) can be employed in compositions of the present invention to counteract bacterial attack and plaque formation. Examples of applicable antimicrobial agents belong to the following types. a) Halogenated salicylanilide free amine compounds, such as those described in U.S. Patent No. 5,344,641, which include: 4 ', 5-dibromosalicylanilide, 3,4', 5-trichlorosalicylanilide, 3,4 ', 5-tribromosalicylanilide , 2,3,3 ', 5-tetrachlorosalicylanilide, 3,3,3', 5-tetrachlorosalicylanilide, 3,5-dibromo-3 '-trifluoromethyl salicylanilide, 5-n-octanoyl-3' -trifluoromethyl salicylanilide, 3, 5 -dibromo-4 '-trifluoromethyl salicylanilide, 3,5-dibromo-3'-trifluoromethyl salicylanilide (fluorophen) Benzoic Esters
Methyl Ester p-hydroxybenzoic Ethyl Ester p-hydroxybenzoic Propyl Ester p-hydroxybenzoic Butyl Ester p-hydroxybenzoic
halogenated diphenylethers, such as those described in U.S. Patent No. 5,344,641, which include: 2 *, 4, 4'-trichloro-2-hydroxy-diphenyl ether (Triclosan) 2 ', 2'-dihydroxy-5, 5 '-dibromo-diphenyl ether. halogenated carbanilides as described in U.S. Patent No. 5,344,641, which includes: 3,4,4'-trichlorocarbanilide, 3-trifluoromethyl-4,4'-dichlorocarbanilide, 3,3,4'-trichlorocarbanilide. Also included are phenolic compounds, representative examples of which are described in U.S. Patent No. 5,290,541, which include phenol, its derivatives and biphenol compounds Specifically include: Phenol and its Homologs
Phenol -Fenol 2 methyl-Phenol 3 methyl-Phenol 4 methyl-Phenol 4 ethyl-Phenol 2,4-dimethyl-Phenol 2,5-dimethyl-Phenol 3,4-dimethyl-Phenol 2,6-dimethyl-Phenol 4-n -propyl -Fenol 4-n-butyl -Fenol 4-n-amyl -Fenol 4-ter-amyl -Fenol 4-n-hexyl -Fenol 4-n-heptyl -Fenol
2-methoxy-4- (2-propenyl) -phenol (Eugenol) 2-isopropy1-5-methy1-phenol (Thymol)
Halofenols of mono and polyalkyl and aralkyl
methyl-p-chlorophenol ethyl-p-chlorophenol n-propyl • p-chlorophenol n-butyl-p-chlorophenol n-amyl-p-chlorophenol sec-amyl-p-chlorophenol n-hexyl -p-chlorophenol cyclohexyl: p-chlorophenol n-heptyl -p-chlorophenol n-octyl-p-chlorophenol
O-chlorophenol methyl -p-chlorophenol ethyl -p-chlorophenol n-propyl -p-chlorophenol n-butyl -p-chlorophenol n-amyl -p-chlorophenol ter-amyl -p-chlorophenol n-hexyl -p-chlorophenol n- heptyl -p-chlorophenol p-chlorophenol o-benzyl-p-chlorophenol o-benzyl-m-methyl -p-chlorophenol o-benzyl-m, m-dime yl -p-chlorophenol or -phenylethyl -p-chlorophenol or -phenylethyl -m-methyl-p-chlorophenol
3-methyl-p-chlorophenol 3,5-dimethyl-p-chlorophenol 6-ethyl-3-methyl-p-chlorophenol
6 -. 6-n-propyl-3-methyl-p-chlorophenol
6-iso-propyl-3-methyl-p-chlorophenol
2-ethyl-3, 5-dimethyl-p-chlorophenol 6-sec-butyl-3-methyl-p-chlorophenol
2-iso-propyl-3, 5-dimethyl-p-chlorophenol
6-diethylmethyl-3-methyl-p-chlorophenol
6-iso-propyl-2-ethyl-3-methyl-p-chlorophenol
2-sec-amyl-3, 5-dimethyl-p-chlorophenol 2-diethylmethyl-3, 5-dimethyl-p-chlorophenol
6-sec-octyl-3-methyl-p-chlorophenol p-bromophenol methyl -p-bromophenol ethyl -p-bromophenol n-propyl-p-bromophenol n-butyl -p-bromophenol n-amyl -p-bromophenol sec-amyl -p-bromophenol n-hexyl-p-bromophenol cyclohexyl-p-bromophenol ter-amyl-p-bromophenol n-hexyl-p-bromophenol n-propyl-mm-dimethyl 2-phenyl phenol 4-chloro-2-methyl phenol 4 -chloro-3-methyl phenol 4-chloro-3,5-dimethyl phenol 2,4-dichloro-3,5-dimethyl phenol 3,4,5,6-tetrabromo-2-methyl phenol 5-methyl-2-pentylphenol 4-isopropyl-3-methylphenol 5-chloro-2-hydroxydiphenylmethane
Resorcinol and its derivatives
resorcinol-resorcinol methyl-resorcinol ethyl-resorcinol n-propyl-resorcinol n-butyl-resorcinol n-amyl-resorcinol n-hexyl-resorcinol n-heptyl-resorcinol n-octyl-resorcinol n-nonyl-resorcinol phenyl-resorcinol benzyl-resorcinol phenylethyl -Resorcinol phenylpropyl -Resorcinol p-chlorobenzyl -Resorcinol 5-chloro-2,4-dihydroxydiphenyl methane 4'-chloro -2,4-dihydroxydiphenyl methane
-bromo -2,4-dihydroxydiphenyl methane
4 '-bromo -2, 4-dihydroxydiphenyl methane
Bisphenol A 2 (2'-methylene bis (4-chlorophenol) 2,2'-methylene bis (3,4,6-trichlorophenol) (hexachlorophenol) 2,2'-methylene bis (4-chloro-6-bromophenol) sulfide of bis (2-hydroxy-3, 5-dichlorophenyl) sulfide of bis (2-hydroxy-5-chlorobenzyl) b) Amine-containing compounds (most quaternary amines) Among the most common antibacterial quaternary ammonium compounds are: alkyldimethylbenzylammonium benzethonium chloride (Hyamine 1622), diisobutylphenoxyethoxyethyl ethyl dimethyl benzyl ammonium chloride and cetylpyridinium halides (chlorine, bromine, iodine, and fluorine). Other materials of this nature are also mentioned in: U.S. Patent Nos. 2,984,639, 3,325,402, 3,431,208, and 3,703,583 and British Patent No. 1,319,396. Further analogous compounds include those in which one or two of the substituents on the quaternary nitrogen have a chain length of carbon atoms (typically alkyl groups) of 8 to 20, typically 10 to 18, carbon atoms while the Remaining substituents have a low number of carbon atoms (typically alkyl or benzyl groups), such as from 1 to 7 carbon atoms, typically methyl or ethyl groups. Typical examples are: dodecyltrimethylamine bromide and benzyldimethylstearylammonium chloride. The preferred antimicrobial materials employed in the present invention pertain to the heterocyclic class compounds derived from nitroparaffins. Examples of such compounds can be classified into the following types: monocyclic oxazolidines, bicyclic oxazolidines, bicyclic polymeric oxazolidines, oxazalines 1-3-dioxanes, oxazolidinones, and hexahydropyrimidines [5-amino-1,3-bis (2-ethylhexyl) -5) -methyl hexahydropyrimidine which is sold under the trade name of "hexetidine" by Angus Chemical Co.], Other antimicrobial substances based on guanine are: 1,6-bis- (p-chlorophenyldiguanidine) hexane, also known under the trade name of "chlorohexidine", 1,6-di- (2-ethylhexildiguanidina) hexane, known as "alexidine", and 1,1 '-hexamethylene-bis-. { 5- (4-fluorophenyl) -diguanidine} also known as "fluorhexidine", In a preferred embodiment of this invention, a non-aqueous dispersion containing microcrystalline wax, paraffin oil and hexetidine is prepared. The resulting mixture is applied to a polyamide dental tape by spreading the tape through the dispersion. After drying, the tape extends over the extracted teeth of humans and the glass rollers. The test and the observation show that a substantial, uniform and continuous coating of a waxed barrier film has been applied to both surfaces of the teeth and the glass rollers. The film is also transferred when the dental and glass surfaces are moistened with water immediately before the treatment. Hydrophobic films of applied materials are not removed by brushing with ten strokes of the toothbrush while submerging in the water. As indicated above, the present compositions may further comprise a source of fluorine, such as sodium fluoride, potassium fluoride, tin fluoride, zinc fluoride, organic fluorides such as long chain aminofluorides, for example oleylamino fluoride, cetylaminofluoride or ethanolaminohydrofluoride, fluorosilicates, for example, potassium hexafluorosilicate or sodium hexafluorosilicate, fluorophosphates such as ammonium, sodium, potassium, magnesium or calcium fluorophosphate and / or fluorozirconates, for example sodium, potassium and tin fluorozirconate. The present compositions may also further comprise one or more antibiotics, such as penicillin, polymyxin B, vancomycin, kanamycin, erythromycin, nidamycin, metronidazole, spiramycin and tetracycline. The present compositions can be prepared by a method in which the barrier material is first suspended or dissolved in an appropriate solvent
(for example, xylene, toluene, petroleum ether, methanol, ethanol or where, for example, aqueous dispersions of fluorocarbons are selected as barrier materials, water). The transfer agent and, optionally, active agents are then added and the solvent removed by, for example, evaporation. The present dental delivery systems can be prepared by coating a suitable substrate (dental floss, toothbrush, toothpick, etc.) with the composition present. This can be conveniently carried out by immersing the substrate in the suspension or solution containing the barrier material, transfer agent, and optionally active agent referred to above in connection with the preparation of the present compositions, and then drying the substrate to remove the solvent, leaving a coating of the present composition on the substrate. Alternatively, the dry composition prepared above can be redissolved or resuspended, and the substrate immersed in the solution or suspension formed in this way, followed by removal of the solvent. The present method of protecting the teeth can be carried out by contacting the dental distribution system with the teeth to effect the transfer of the composition of the dental distribution system to the surface of the teeth. The exact means of contacting will of course depend on the nature of the dental distribution system. In this way, in the case of a dental floss, passing the silk will suffice, while brushing will suffice, in the case of a toothbrush. Rubbing will be appropriate for both toothpicks and cotton swabs. Other features of the invention will become apparent in the course of the following descriptions of the exemplary embodiments which are given for illustration of the invention and are not intended to be limiting thereof.
EXAMPLES In the following examples, and in full their specifications, all parts and percentages are given by weight, and all temperatures are in degrees Celsius, unless expressly stated otherwise. Where the solids content of a dispersion or solution is reported, it expresses the weight of the solids based on the total weight of the dispersion or solution, respectively. Where a molecular weight is specified, this is the molecular weight range assigned to the product by the commercial supplier, which is identified. It is generally believed to be the average weight of the molecular weight. In all the following examples in which the teeth are mentioned, the teeth are teeth extracted from humans which are professionally cleaned with abrasives, sterilized by the auto-clave several times and, prior to their use in the following examples, hydrated in water distilled at least one hour. Immediately prior to the use of the teeth, they are submerged and removed from a mixture of distilled water and fresh human saliva (at approximately 1: 1 by volume), so that the treated surfaces are moist at the time of application of the materials. Example I: 43 grams of xylene solvent sold by EM Science, 5 grams of microcrystalline wax sold by Calwax under the trade designation of Victory White and 2 grams of paraffin oil, 340-355 Saybolt viscosity, sold by EM Science, heat to approximately 50 ° C and mix vigorously until a clear solution is produced. The mixture is allowed to cool to room temperature and 0.125 grams of N-tallow-1,3-propanediamine sold by Akzo under the trade designation of Duomeen TDO (as the transfer agent) is mixed by stirring. The result is a mixture in which the microcrystalline wax appears to be uniformly dispersed but not dissolved in the solvent. A cotton tip applicator is immersed in this mixture and the solvent is allowed to evaporate at an elevated temperature of about 50 ° C. The coated applicator is then rubbed against a tooth surface until a uniform and water-repellent film is obtained, the surface of the tooth has been moistened with 1: 1 by volume of distilled water mixture and fresh human saliva, immediately before the application of the coated applicator (see Figure 3). In order to determine the degree of hydrophobicity imparted by the waxed film, drops of water are deposited on the surface of the film and their contact angles are measured. Repeated measurements show values in excess of 90 ° C that indicate a strong tendency of the surface to repel water.
Demonstration of In Vitro Efficacy The inhibition-absorption ability of the bacterium of each formulation thus obtained is evaluated as follows: a pure culture of bacteria obtained from the American Type Culture Collection (ATCC), (designated ATCC # 27607, and identified as Streptococcus sobrinus, the same organisms that also have and have been previously designated and identified as Streptococcus mutans), are maintained by their culture on fresh brain-heart infusion agar plates and incubating in a C02 incubator at 37 ° C. To prepare a test medium, a small amount of bacteria is transferred to 4 ml of liquid brain heart infusion medium (BHI) (obtained from Curtis Matheson) and incubated for 24 hours at 37 ° C. After the incubation period the concentration of the bacteria in the inoculum is adjusted, with sterilized BHI medium, to approximately 2 x 107 cells / ml (OD560 = 0.02). The contact bacteria solution (0.3 ml) of the above is added to 30 ml of BHI medium containing 4% sucrose and which is in motion at 120 strokes / minute for 3 minutes. Test samples from the untreated teeth and teeth coated with the transfer film are placed in the inoculum medium and incubated under anaerobic conditions at 37 ° for 48 hours. After the removal of the medium, the teeth are rinsed in water and stained with the crystal violet dye. Microscopic examination reveals a significant inhibition of the adhesion of bacteria in the areas covered by the transferred films compared to the untreated control surfaces which are covered by heavy deposits of adherent bacteria. Example II: A mixture is prepared as described in Example I. A polyamide dental floss, such as that manufactured by Johnson & Johnson, Inc., is pulled through and vertically out of the mix at a rate of 3 mm per second, the thickness of the coating is controlled by the speed at which the silk passes through the mixture. Following the drying of air at an elevated temperature, a short chain of silk, approximately 2 feet long, is passed backwards and four times crosses the surfaces of the tooth (central incisors extracted from human), imitating a normal procedure of passing the silk, until a uniform and hard adherent film is produced (see Figure 7). The film exhibits a high degree of hydrophobicity as tested by measurements of contact angles in excess of 90 ° C. The adhesion of the bacteria to the surfaces of the tooth is evaluated according to the procedure indicated in Example I. Significant inhibition of the adhesion of bacteria to the transfer film is observed.
Example III: A mixture is prepared as described in Example I. The wooden toothpicks are immersed in the mixture and slowly removed. After drying at room temperature, the toothpicks are rubbed on the extracted and moistened tooth surfaces until a uniform and continuous film is formed. In addition, in order to determine the degree of hydrophobicity imparted by the waxed film, drops of water are deposited on the surface of the film. Repeated measurements of the contact angles show values above 90 ° which indicate a high degree of hydrophobicity of the interface. The exposure of the treated teeth in the bacteria medium for 48 hours or more demonstrates a significant reduction in the absorption of bacteria, comparable to the reduction observed in Examples I and II. Example IV: A mixture is prepared as described in Example I. Ordinary toothbrushes, some of which the bristles are "natural" and some nylon fibers, are immersed in the mixture and removed at a rate of about 3. mm / second. After drying at high temperature, the toothbrushes are passed several times on the surfaces of the teeth, simulating the action and movement of the tooth brushing (see Figure 5) the treated surfaces of the teeth are then observed by the microscope. Substantial, uniform and continuous layers of the deposited wax material appear on the surface of the tooth. In addition, in order to determine the degree of hydrophobicity imparted by the wax film, drops of water are deposited on the transferred films and the contact angles are measured. Repeated measurements show values above 90 ° that indicate the high degree of hydrophobicity of the surfaces. A significant inhibition of the adhesion of bacteria to the transferred film is observed. Example V: 43 grams of xylene solvent sold by EM Science, 5 grams of microcrystalline wax coming from Calwax under the trade name of Victory White and 2 grams of paraffin oil, 340-355 Saybolt viscosity, sold by EM Science. heat to approximately 50 ° C and mix vigorously until a clear solution is produced. The mixture is allowed to cool to room temperature. Then, 0.2 grams of cetylamine sold by Aldrich (as transfer agent) is mixed by stirring. The result is a mixture in which the microcrystalline wax appears to be uniformly dispersed but not completely dissolved in the solvent. The cotton end applicators are immersed in this mixture and removed, allowing the solvent to evaporate at an elevated temperature. The coated applicator is then rubbed against the moistened glass guides until a uniform and water repellent film is obtained. In order to determine the degree of hydrophobicity imparted by the wax film, drops of water are deposited on the surface of the film and the contact angles are measured. Repeated measurements show values greater than 90 ° indicating a strong tendency of the surface to repel water. The adhesion of the bacteria to the surfaces of the tooth is evaluated according to the procedure indicated in Example I. Significant inhibition of the adhesion of bacteria to the barrier film is observed. Example VI: A mixture is prepared as described in Example V. A polyamide dental floss, such as that manufactured by Johnson & amp; amp;; Johnson, Inc. is passed through and vertically out of the mixture at a rate of about 3 mm per second, the thickness of the coating being controlled by the speed at which the silk passes through the mixture. Following an air drying at elevated temperature, a short string of silk, approximately 2 feet in length, is passed and crossed over the surfaces of the teeth, imitating a process of passing the normal silk until a uniform adherent film and it lasts. The film exhibits a high degree of hydrophobicity as evidenced by measurements of contact angles greater than 90 °. The adhesion of the bacteria to the surfaces of the tooth is evaluated according to the procedure indicated in Example I. Significant inhibition of bacterial adhesion to the film is observed. Example VII: A mixture is prepared as described in Example V. Wooden toothpicks are immersed in the mixture and slowly removed. After drying at room temperature, the toothpicks are repeatedly rubbed onto the surfaces of the moistened tooth until a uniform and continuous film is formed. In addition, in order to determine the degree of hydrophobicity imparted by the wax film, drops of water are deposited on the surface of the film and the contact angles are measured. The repeated measurements show values of 90 ° C that indicate a high degree of hydrophobicity of the interface. The exposure of the treated teeth to the bacteria medium results in a significant reduction in the absorption of bacteria compared to the reduction observed in Examples V and VI.
Example VIII: A mixture is prepared as described in Example V. Ordinary toothbrushes, some of which the bristles are of "natural" fibers and some of nylon, are immersed in the mixture and slowly removed. After drying at high temperature, the toothbrushes are passed several times over the surfaces of the teeth, moistened, simulating the action and movement of tooth brushing. The treated surfaces of the teeth are then observed by the microscope. Substantial, uniform and continuous layers of the deposited wax material appear on the surface of the tooth. In addition, in order to determine the degree of hydrophobicity imparted by the wax film, drops of water are deposited on the transferred films and the contact angles are measured. Repeated measurements show values above 90 ° that indicate the high degree of hydrophobicity of the surfaces. Incubation for 48 hours in the bacteria medium shows a significant inhibition of bacterial adhesion. It is further noted that the subsequent brushing, while both teeth and toothbrushes are immersed in water, result in the complete removal of the bacteria from the wax film while around the untreated areas remain covered by the bacterial colonies.
Elevation of Bacterial Attack Inhibition and / or Propagation. Growth and Colonization: A significant elevation in the efficacy of the barrier film to inhibit the adhesion of bacterial colonies is realized when various antibacterial agents such as hexetidine, for example, are incorporated into the formulation. Examples IX to XII demonstrate the effectiveness of this method. Example IX: 43 grams of xylene solvent sold by MS
Science, 5 grams of microcrystalline wax coming from Calwax under the trade designation of Victory White and 2 grams of paraffin oil, 340-355 Saybolt viscosity, sold by EM Science are heated to approximately 50 ° C and mixed vigorously until a transparent solution occurs. The mixture is allowed to cool to room temperature. Then, 0.3 grams of Duomeen TDO (AKZO Chemical Co.) (as a transfer agent) is mixed by stirring. To this mixture is added 1.25 grams of 5-amino-l, 3-bis (2-ethylhexyl) -5-methylhexahydropyrimidine sold by Angus Chemical Co., under the trade designation of hexetidine (as active agent) with vigorous mixing. The result is a mixture in which the microcrystalline wax appears to be uniformly dispersed but not dissolved. The applicator with cotton tip is immersed in this mixture and the solvent evaporates at elevated temperature. The coated applicator is then rubbed against the glass guides until a uniform and water-repellent film is obtained, the guide that has been moistened with distilled water immediately prior to application of the applicator. In order to determine the degree of hydrophobicity imparted by the wax film, drops of water are deposited on the surface of the film and the contact angles are measured. Repeated measurements show values greater than 90 ° indicating a strong tendency of the surface to repel water. The ability of the barrier film to inhibit the absorption of bacteria is evaluated as described in Example I. A negligible number of bacterial colonies, compared to the untreated control areas adjacent to the film are observed even after 4 days of exposure to the medium that has bacteria. Example X: A mixture is prepared as described in Example IX. A polyamide dental floss, such as that manufactured by Johnson & Johnson, Inc. is passed through and vertically out of the mixture at a rate of about 3 mm per second, the thickness of the coating being controlled by the speed at which the silk passes through the mixture. Following with an air drying at high temperature, a short chain of silk, approximately 2 feet in length, is passed between and back from the surfaces of the teeth, (central incisors extracted from human), imitating a normal procedure of passing the silk, until a uniform and hard adherent film is produced. The film exhibits a high degree of hydrophobicity as tested by measurements of contact angles greater than 90 ° C. The adhesion of the bacteria to the surfaces of the treated tooth is evaluated according to the procedure indicated in Example I. Examination by microscope (Figure 8a and 8b) reveal that the area covered by the transferred film is substantially free of bacterial colonies while that around untreated control areas are covered by heavy deposits of absorbed bacteria. Example XI: A mixture is prepared as described in Example IX. The wooden toothpicks are immersed in the mixture and removed. After drying at room temperature, the toothpicks are repeatedly rubbed onto the surfaces of the moistened tooth until a uniform and continuous film is formed. In addition, in order to determine the degree of hydrophobicity imparted by the wax film, drops of water are deposited on the surface of the film and the contact angles are measured. Repeated measurements show values greater than 90 ° C that indicate a high degree of hydrophobicity of the interface. The exposure of the treated teeth in the bacteria medium results in a negligible amount of colonies of isolated bacteria adhering to the surface of the film. Example XII: A mixture is prepared as described in Example IX. Ordinary toothbrushes, some of which the bristles are made of "natural" fibers and some of nylon, are submerged in the mixture and slowly removed. After drying at high temperature, the toothbrushes are passed several times over the surfaces of the teeth, moistened, simulating the action and movement of tooth brushing. The treated surfaces of the teeth are then observed by the microscope. Substantial, uniform and continuous layers of the deposited wax material appear on the surface of the tooth. In addition, in order to determine the degree of hydrophobicity imparted by the wax film, drops of water are deposited on the transferred films and the contact angles are measured. Repeated measurements show values above 90 ° that indicate the high degree of hydrophobicity of the surfaces. Incubation for 48 hours in the bacteria medium shows a high resistance of the film to react with any component of the media including bacteria (Figure 6a and 6b). Microscopic observations fail to detect any residual bacteria or bacterial colonies after the surface of the treated tooth is gently brushed with a toothbrush under running water. Example XIII: 83.5 grams of xylene solvent sold by EM Science, 10 grams of microcrystalline wax coming from Calwax under the trade designation of Victory White and 4 grams of paraffin oil, 340-355 Saybolt viscosity, sold by EM Science. heat to approximately 50 ° C and mix vigorously until a clear solution is produced. The mixture is allowed to cool to room temperature. For this mixture 2.5 g of 5-amino-l, 3-bis (2-ethylhexyl) -5-methylhexahydropyrimidine sold by Angus Chemical Co., under the commercial designation of hexetidine (as a transfer agent and active agent) is added with mixing vigorous. The result is a mixture in which the microcrystalline wax appears to be uniformly dispersed but not completely dissolved. The applicator with cotton tip is immersed in this mixture and the solvent is evaporated at high temperature (40-50 ° C). The coated applicator is then rubbed against the surfaces of the tooth until a uniform and water repellent film is obtained. In order to determine the degree of hydrophobicity imparted by the wax film, drops of water are deposited on the surface of the film and the contact angles are measured. Repeated measurements show values greater than 90 ° indicating a strong tendency of the surface to repel water. The adhesion of the bacteria to the treated surfaces is evaluated according to the procedure indicated in Example I. Microscopic examination shows that the treated surface areas of the teeth are essentially free of the absorbed bacteria while the control surfaces do not. treated are loaded with heavy deposits of colonies of adherent bacteria (Figures 4a and 4b). Example XIV: 84.75 grams of xylene solvent sold by EM Science, 10 grams of microcrystalline wax sold by Calwax under the trade designation of Victory White and 4 grams of paraffin oil, 340-355 Saybolt viscosity, sold by EM Science, heat to approximately 50 ° C and mix vigorously until a clear solution is produced. The mixture is allowed to cool to room temperature. To this mixture is added 1.25 grams of N-tallow-1,3-propanediamine diolate sold by Akzo Nobel Chemicals Inc., under the trade designation of Duomeen TDO (as a transfer agent and active agent) with vigorous mixing. The result is a mixture in which the microcrystalline wax appears to be uniformly dispersed but not completely dissolved. A cotton end applicator is immersed in this mixture and the solvent is allowed to evaporate at an elevated temperature (40-50 ° C). The cotton applicator is rubbed against a glass guide until a uniform and water-repellent film is obtained. In order to determine the degree of hydrophobicity imparted by the waxed film, drops of water are deposited on the surface of the film and their contact angles are measured. Repeated measurements show values greater than 90 ° indicating a strong tendency of the surface to repel water. The adhesion of the bacteria to the barrier film is evaluated according to the procedure indicated in Example I. Significant inhibition of the adhesion of bacteria to the barrier film is observed. Example XV: 4.3 grams of polyethyleneimine (1/10 segmental molecular weight) and 15.2 grams of stearyol chloride (1/20 moles) are dissolved in 25 ml of ethanol and brought to gentle reflux for 30 minutes. After cooling to room temperature, 25 ml of a 25% aqueous solution of silver fluoride is added and the mixture is stirred for 10 minutes. The silver chloride is removed and the unpurified derivative is purified by crystallization. The crystalline derivative is transferred to a plastic beaker and dissolved in 25 ml of ethanol. 3.0 grams of 40% hydrofluoric acid (1/20 mol + 20%) is added to the solution and the -totality is then evaporated in a water bath until its consistency is similar to a paste. The remaining solvent is removed in vacuo to about 50 ° C. The compound remains as a brown colorless paste. It is soluble in alcohols and solvents based on hydrocarbons. Obviously, numerous modifications and variations of the present invention are possible in light of the above teachings. It is therefore understood that, within the scope of the appended claims, the invention may be practiced otherwise than as specifically described herein. All patents and other references mentioned in the foregoing are fully incorporated herein, by this reference, the same as indicated.
Claims (6)
- Phenol, 2-methyl-phenol, 3-methyl-phenol, 4-methyl-phenol, 4-ethyl-phenol, 2,4-dimethyl-phenol, 2,5-dimethyl-phenol, 3,4-dimethyl-phenol, 2, 6-dimethyl-phenol, 4-n-propyl-phenol, 4-n-butyl-phenol, 4-n-amyl-phenol, 4-tert-amyl-phenol, 4-n-hexyl-phenol, -n heptyl-phenol, 2-methoxy-4- (2-propenyl) -phenol, 2-isopropyl-5-methyl-phenol, methyl-p-chlorophenol, ethyl-p-chlorophenol, n-propyl-p-chlorophenol, n-butyl-p-chlorophenol, n-amyl-p-chlorophenol, sec-ami1- p-chlorophenol n-hexyl-p-chlorophenol, cyclohexyl-p-chlorophenol, n-heptyl-p-chlorophenol, n-octyl-p-chlorophenol, methyl-o-chlorophenol, ethyl-o-chlorophenol, n-propyl-o -chlorophenol, n-butyl-o-chlorophenol, n-amyl-o-chlorophenol, tert-amyl-o-chlorophenol, n-hexyl-o-chlorophenol, n-heptyl-o-chlorophenol, o-benzyl-p-chlorophenol , o-benzyl-m-methyl-p-chlorophenol, o-benzyl-m, m-dimethyl-p-chlorophenol, o-phenylethyl-p-chlorophenol, o-phenylethyl-m-methyl-p-chlorophenol, 3 - . 3-methyl-p-chlorophenol, 3,5-dimethyl-p-chlorophenol, 6-ethyl-3-methyl-p-chlorophenol, 6-n-propyl-3-methyl-p-chlorophenol, 6 -. 6-isopropyl-3-methyl-p-chlorophenol, 2 - . 2 - . 2-ethyl-3,5-dimethyl-p-chlorophenol, 6 -sec-butyl-3-methyl-p-chlorophenol, 2-isopropyl-3,5-dimethyl-p-chlorophenol, 6-diethylmethyl-3-methyl-p-chlorophenol, 6-iso-propyl-2-ethyl-3-methyl-p-chlorophenol, 2-sec-amyl-3, 5-dimethyl-p-chlorophenol,
- 2-diethylmethyl-3,5-dimethyl-p-chlorophenol, 6-sec-octyl-3-methyl-p-chlorophenol, methyl-p-bromophenol, ethyl-p-bromophenol, n-propyl-p-bromophenol, n-butyl-p-bromophenol, n-amyl-p-bromophenol, sec-amyl-p-bromophenol, n-hexyl-p-bromophenol, cyclohexyl-p-bromophenol, tert-amyl-o-bromophenol, n-hexyl-o-bromophenol, n-propyl-mm-dimethyl-o-bromophenol, 2-Phenylphenol, 4-chloro-2-methylphenol, 4-chloro-3-methylphenol, 4-chloro-3,5-dimethylphenol, 2,4-dichloro-3,5-dimethylphenol, 3,4,5,6- tetrabromo-2-methylphenol, 5-methyl-2-pentylphenol, 4-isopropi1-3- eti1fenol, 5-chloro-2-hydroxydiphenylmethane, resorcinol methyl-resorcinol, ethyl-resorcinol, n-propyl-resorcinol, n-butyl- resorcinol, n-amyl-resorcinol, n-hexyl resorcinol, n-heptyl-resorcinol, n-octyl-resorcinol, n-nonyl-resorcinol, phenyl-resorcinol, benzyl-resorcinol, phenylethyl-resorcinol, phenylpropyl-resorcinol, p- chlorobenzyl-resorcinol, 5-chloro-2, 4 -dihidroxidifenilmetano, 4 '-chloro-2, 4 -dihidroxidifenilmetano, 5-bromo-2, 4 -dihidroxidifenilmetano, 4'-bromo-2, 4 -dihidroxidifenilmetano, 2,2' -met ilen bis (4-chlorophenol), 2,2'-methylene bis (3,4,6-trichlorophenol), 2,2'-methylene bis (4-chloro-6-bromophenol), bis (2-hydroxy) sulfide 3, 5-dichlorophenyl) sulfide bis (2-hydroxy-5-chlorobenzyl), benzethonium chloride, diisobutylphenoxyethoxyethyl dimethyl benzyl ammonium chloride, cetylpyridinium chloride, cetylpyridinium bromide, iodide, cetylpyridinium fluoride, cetylpyridinium dodecyltrimethylammonium bromide , benzyldimethylstearylammonium chloride, monocyclic oxazolidines, bicyclic oxazolidines, bicyclic oxazolidines polymer, oxazalidinas 1-3-dioxanes, oxazolidinones, 5-amino-l, 3-bis (2-ethylhexyl) -5-methyl hexahidropiri idina, 1, 6-bis - (p-chlorophenyldiguanidine) hexane, 1,6-di- (2-ethylhexyldiguanidine) hexane, 1,1'-hexamethylene-bis-. { 5- (4-fluorophenyl) -diguanidine} , Sodium fluoride, potassium fluoride, tin fluoride, zinc fluoride, oleilamino-fluoride, cetilamino-fluoride, etanolaminohidrofluoruro, potassium hexafluorosilicate, sodium hexafluorosilicate, sodium fluorophosphate, ammonium fluorophosphate, fluorophosphate, potassium fluorophosphate, magnesium , calcium fluorophosphate fluorozirconate sodium, fluorozirconate potassium tin fluorozirconate penicillin, polymyxin B, vancomycin, kanamycin, erythromycin, nidamycin, metronidazole, spiramycin and tetracycline. The method according to claim 17, characterized in that the composition comprises from 2 to 5% by weight, based on the total weight of (a1), (b1) and (c ') of the transfer agent; from 85 to 93% by weight, based on the total weight of (a '), (b') and (C) of the barrier material; and 5 to 10% by weight, based on the total weight of (a '), (b1) and (c') of the active agent. 19. The method according to claim 17, characterized in that the transfer agent is 5-amino-1,3-bis (2-ethylhexyl) -5-methylhexahydropyrimidine. The method according to claim 17, characterized in that the transfer agent is polyethyleneimine in which 5 to 95% mol of the nitrogen atoms have been derived by reaction with a fatty acid halide of C8_20 and from 5 to 95 % in mol of the nitrogen atoms have been quaternized with HF. 21. The method according to claim 17, characterized in that the barrier material is a microcrystalline wax. 22. The method according to claim 17, characterized in that the active agent is 1,6-bis- (p-chlorophenyldiguanidine) hexane. 23. A dental delivery system, characterized in that it comprises a substrate coated with a composition comprising: (a) from 1 to 20% by weight, based on the total weight of (a) and (b) of a transfer agent; and (b) from 80 to 99% by weight, based on the total weight of (a) and (b) of a barrier material, wherein the transfer agent is selected from the group consisting of the compounds of the formula ( I), (II) and (III): R 'R « (I) (II) (III) where R represents an alkyl chain (C8_Q), which can be substituted with one or more hydroxy groups, R ', R "and R"' each independently are an alkyl chain (Cg_20), which can be substituted with one or more hydroxy groups, an alkyl 1-4) / which may be substituted with one or more hydroxy groups, an aryl group (C6_10) or hydrogen, and X is fluorine or chlorine; laurylpyridinium chloride; laurylpyridinium bromide; cetylpyridinium chloride; cetylpyridinium bromide; cetylpyridinium fluoride; cationic petroleum derivatives; polydimeryl polyamines; polyamines; polyacrylamides, polydiallyl dimethyl ammonium chlorides, polyhexamethylene biguanides; 1, 5-dimethyl, 5-diazaundecamethylene polymethobromide; polyvinyl pyrrolidones; polypeptides, poly (allylamine) hydrochloride; polyoxyethylene amines; polyethylene imines; acylated polyethylenimines; diethylaminoethyl cellulose; poly (vinyl-benzylstearylbetaine); poly (vinylbenzylmethylaurylammonium chloride) poly (vinylbenzyluril pyridylpyridinium chloride) poly (vinylbenzylcetylmonylhexylether) compound of the formula RN (CH3) [CC2HyO)? H] 2 (+) A (-) wherein A (-) is chloro or fluoro, X is a number from 1 to 20 and R is C8_22 / 'polyacrylamide alkyl in which 5 to 95 mol% of the nitrogen atoms have been derived by reaction with a halide of C8_20 fatty acid and 5 to 95 mol% of the nitrogen atoms have been quaternized with HF; polyvinylpyridine in which 5 to 95 mol% of the nitrogen atoms have been derived by reaction with a fatty acid halide of Cg_20 and 5 to 95 mol% of the nitrogen atoms have been quaternized with HF; and 5-amino-l, 3-bis (2-ethylhexyl) -5-methylhexahydropyrimidine; and wherein the barrier material is selected from the group consisting of beeswax, lanolin, sperm, carnauba wax, paraffin waxes, microcrystalline waxes, petrolatum waxes, ethylene polymer waxes, polymethylene waxes, polymethylalkysiloxane, polydimethylsiloxane, poly. { perfluoroalkylmethylsiloxane), poly (methyl-3, 3, 3-tri-fluoropropylsiloxane), polytetrafluoroethylene, fluorinated polyethylene-propylene, polyvinylidene fluoride and polyvinyl fluoride. 24. The dental delivery system according to claim 23, characterized in that it comprises a composition of 3 to 5% by weight, based on the total weight of (a) and (b) of the transfer agent; and 95 to 97% by weight, based on the total weight of (a) and (b) of a barrier material. 25. The dental delivery system according to claim 23, characterized in that the transfer agent is 5-amino-l, 3-bis (2-ethylhexyl) -5-methylhexahydro-pyrimidine. 26. The dental delivery system according to claim 23, characterized in that the transfer agent is polyethyleneimine in which 5 to 95 mol% of the nitrogen atoms have been derived by reaction with a fatty acid halide of C8_20 and 5 to 95% by mole of the nitrogen atoms have been quaternized with HF. 27. The dental delivery system according to claim 23, characterized in that the barrier material is a microcrystalline wax. 28. A dental delivery system characterized in that it comprises a substrate coated with a composition comprising: (a ') from 1 to 10% by weight, based on the total weight of (a'), (b ') and (C) ) of a transfer agent; (b ') from 70 to 98% by weight, based on the total weight of (a'), (b ') and (c1) of a barrier material; and (c1) 1 to 20% by weight, based on the total weight of (a '), (b1) and (c') of an active agent; wherein the transfer agent is selected from the group consisting of the compounds of the formula (I), (II) and (III): R 'R' R 'III RNR "RN ± HX" RN ± R "X" (I ) (II) (III) where R is an alkyl chain of C8_2Q, which can be substituted with one or more hydroxy groups, R ', R "and R"' each independently are an alkyl chain of C8-20 '^ to which ^ - Can to be substituted with one or more hydroxy groups, a C1_4 alkyl group, which may be substituted with one or more hydroxy groups, an aryl group of c6-10 ° hydrogen, and X is fluorine or bromine; laurylpyridinium chloride; laurylpyridinium bromide; cetylpyridinium chloride; cetylpyridinium bromide; cetylpyridinium fluoride; cationic petroleum derivatives; polydimeryl polyamines; polyamides; polyacrylamides, polydiallyl dimethyl ammonium chlorides, polyhexamethylene biguanides; 1, 5-dimethyl-l, 5-diazaundecamethylene polymethobromide; polyvinyl pyrrolidones; polypeptides, poly (allylamine) hydrochloride; polyoxyethylene amines; polyethylene imines; acylated polyethylenimines; diethylaminoethyl cellulose; poly (vinyl-benzylstearylbetaine); poly (vinylbenzylmethylaurylammonium chloride; poly (vinylbenzyluril pyridylpyridinium) chloride; poly (vinylbenzylcetylmonylhexylether); compound of the formula RN (CH3) [CC2HyO)? H] 2 (+) A (-) wherein A (-) is chloro or fluoro, X is a number from 1 to 20 and R is an alkyl group of 8-22 polyacrylamide in which 5 to 95 mol% of the nitrogen atoms have been derived by reaction with a fatty acid halide of Cg_2n and 5 to 95% by mol of the nitrogen atoms have been quaternized with HF; polyvinylpyridine in which 5 to 95 mol% of the nitrogen atoms have been derivatized by reaction with a fatty acid halide of C2Q and 5 to 95 mol% of the nitrogen atoms have been quaternized with HF; and 5-amino-1,3-bis (2-ethylhexyl) -5-methylhexahydropyrimidine; wherein the barrier material is selected from the group consisting of beeswax, lanolin, sperm, carnauba wax, paraffin waxes, microcrystalline waxes, petrolatum waxes, ethylene polymer waxes, polymethylene waxes, polymethylalkysiloxane, polydimethylsiloxane, poly (perfluoroalkylmethylsiloxane), poly (methyl-3,3,3-tri-fluoropropylsiloxane), polytetrafluoroethylene, fluorinated polyethylene-propylene, polyvinylidene fluoride and polyvinyl fluoride, and wherein the active agent is selected from a group consisting of: 4 ' , 5-dibromosalicylanilide, 3,4 ', 5-trichlorosalicylanilide, 3,4', 5-tribromosalicylanilide, 2,3,3 ', 5-tetrachlorosalicylanilide, 3,3,3', 5-tetrachlorosalicylanilide, 3,5-dibromo -3'-trifluoromethyl salicylanilide, 5-n-octanoyl-3'-trifluoromethyl salicylanilide, 3,5-dibromo-4'-trifluoromethyl salicylanilide, 3,5-dibromo-3'-trifluoromethyl salicylanilide Ester of methyl p-hydroxybenzoic Ester of ethyl p-hydroxybenzoic o Propyl p-hydroxybenzoic ester 2-butyl p-hydroxybenzoic ester, 4, 4'-trichloro-2-hydroxy-diphenyl ether 2 ', 2' -dihydroxy-5, 5 '-dibromo-diphenyl ether 3,4,4'-trichlorocarbanilide, 3-trifluoromethyl-4,4'-dichlorocarbanilide, 3,3,4'-trichlorocarbanilide Phenol, 2-methyl-phenol, 3-methyl-phenol, 4-methyl-phenol, 4-ethyl-phenol, 2,4-dimethyl-phenol, 2,5-dimethyl-phenol, 3, 4-dimethyl-phenol, 2,6-dimethyl-phenol, 4-n-propyl-phenol, 4-n-butyl-phenol, 4-n-amyl-phenol, 4-tert-amyl-phenol, 4- n-hexyl-phenol, 4-n-heptyl-phenol, 2-methoxy-4- (2-propenyl) -phenol, 2-isopropyl-5-methyl-phenol, methyl-p-chlorophenol, ethyl-p-chlorophenol, n-propyl-p-chlorophenol, n-butyl p-chlorophenol, n-amyl p-chlorophenol, sec-AMI1-p-chlorophenol n-hexyl-p-chlorophenol, cyclohexyl-p-chlorophenol, n-heptyl-p chlorophenol, n-octyl-p-chlorophenol, o-chlorophenol methyl, ethyl o-chlorophenol-n-propyl-o-chlorophenol, n-butyl-o-chlorophenol, n-amyl-o-chlorophenol, tert-AMI1 -o-chlorophenol, n-hexyl-o-chlorophenol, n-heptyl-o-chlorophenol, o-benzyl-p-chlorophenol, o-benzyl-m-methyl-p-chlorophenol, o-benzyl-m, m-dimethyl -p-chlorophenol, o-phenylethyl-p-chlorophenol, o-phenylethi-1-m-methyl-p-chlorophenol,
- 3 - . 3-yl-p-chlorophenol, 3, 5-dimethyl-p-chlorophenol, 6-ethyl-3-methyl-p-chlorophenol, 6-n-propyl-3-methyl-p-chlorophenol, 6-isopropyl -3-methyl-p-chlorophenol, 2-ethyl-3, 5-dimethyl-p-chlorophenol, 6 -sec-butyl-3-methyl-p-chlorophenol, 2-iso-propyl-3, 5-dimethyl-1-p -chlorophenol, 6-diethylmethyl-3-methyl-p-chlorophenol, 6-isopropyl-2-ethyl-3-methyl-p-chlorophenol, 2-sec-amyl-3,5-dimethyl-p-chlorophenol, 2-diethylmethyl-3,5-dimethyl-p-chlorophenol, 6 -. 6-sec-octyl-3-methyl-p-chlorophenol, methyl-p-bromophenol, ethyl-p-bromophenol, n-propyl-p-bromophenol, n-butyl-p-bromophenol, n-amyl-p-bromophenol, sec-amyl-p-bromophenol, n-hexyl-p-bromophenol, cyclohexyl-p-bromophenol, tert-amyl-o-bromophenol, n-hexyl-o-bromophenol, n-propyl-mm-dimethyl-o-bromophenol, 2-phenylphenol, 4-chloro-2-methylphenol, 4-chloro-3-methylphenol, 4-chloro-3,5-dimethylphenol, 2,4-dichloro-3,5-dimethylphenol, 3,4,5,6- tetrabromo-2-methylphenol, 5-methyl-2-pentylphenol, 4-isopropyl-3-methylphenol, 5-chloro-2-hydroxydiphenylmethane, resorcinol methyl-resorcinol, ethyl-resorcinol, n-propyl-resorcinol, n-butyl- resorcinol, n-amyl-resorcinol, n-hexyl resorcinol, n-heptyl-resorcinol, n-octyl-resorcinol, n-nonyl-resorcinol, phenyl-resorcinol, benzyl-resorcinol, phenylethyl-resorcinol, phenylpropyl-resorcinol, p- chlorobenzyl-resorcinol, 5-chloro-2,4-dihydroxydiphenylmethane,
- 4'-chloro-2, -dihydroxydiphenylmethane,
- 5-bromo-2,4-dihydroxydiphenylmethane, 4'-bromo-2,4-dihydroxydiphenylmethane, 2,2'-methylene bis (4-chlorophenol), 2,2'-methylene bis (3,4,
- 6-trichlorophenol), 2,2 '-methylene bis (4-chloro-6-bromophenol), sulfur bis (2-hydroxy-3, 5-dichlorophenyl) sulfide bis (2-hydroxy-5-chlorobenzyl), benzethonium chloride, diisobutylphenoxyethoxyethyl dimethyl benzyl ammonium chloride, cetylpyridinium chloride, cetylpyridinium bromide, iodide, cetylpyridinium fluoride cetylpyridinium, dodecyltrimethylammonium bromide, benzyldimethylstearylammonium chloride, monocyclic oxazolidines, bicyclic oxazolidines, polymeric bicyclic oxazolidines, oxazalidines 1-3-dioxanes, oxazolidinones, 5-amino-1,3-bis (2-ethylhexyl) -5-methyl hexahydropyrimidine, , 6-bis- (p-chlorophenyldiguanidine) hexane, 1,6-di- (2-ethylhexyldiguanidine) hexane, 1,1'-hexamethylene-bis-. { 5- (4-fluorophenyl) -diguanidine} , sodium fluoride, potassium fluoride, tin fluoride, zinc fluoride, oleylamino fluoride, cetylamino fluoride, ethanolaminohydrofluoride, potassium hexafluorosilicate, sodium hexafluorosilicate, sodium fluorophosphate, ammonium fluorophosphate, potassium fluorophosphate, magnesium fluorophosphate . calcium fluorophosphate sodium fluorozirconate, potassium fluorozirconate fluorozirconate of tin penicillin, polymyxin B, vancomycin, kanamycin, erythromycin, niddamycin, metronidazole, spiramycin and tetracycline. 29. The dental delivery system according to claim 28, characterized in that the composition comprises from 2 to 5% by weight, based on the total weight of (a '), (b1) and (c') of the transfer; from 85 to 93% by weight, based on the total weight of (a '), (b1) and (c1) of the barrier material; and 5 to 10% by weight, based on the total weight of (a '), (b') and (c ') of the active agent. 30. The dental delivery system according to claim 28, characterized in that the transfer agent is 5-amino-l, 3-bis (2-ethylhexyl) -5-methylhexa-hydropyrimidine. 31. The dental delivery system according to claim 28, characterized in that the transfer agent is polyethyleneimine in which 5 to 95% mol of the nitrogen atoms have been derived by reaction with a fatty acid halide of Cg_2Q and 5 to 95 mol% of the nitrogen atoms have been quaternized with HF. 32. The dental delivery system according to claim 28, characterized in that the barrier material is a microcrystalline wax. 33. The dental delivery system according to claim 28, characterized in that the active agent is 1,6-bis- (p-chlorophenyldiguanidine) hexane.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/373,946 US5665333A (en) | 1995-01-17 | 1995-01-17 | Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth |
US08373946 | 1995-01-17 | ||
PCT/US1995/016393 WO1996022078A1 (en) | 1995-01-17 | 1995-12-27 | Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth |
Publications (2)
Publication Number | Publication Date |
---|---|
MXPA97005403A true MXPA97005403A (en) | 1998-02-01 |
MX9705403A MX9705403A (en) | 1998-02-28 |
Family
ID=23474572
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9705403A MX9705403A (en) | 1995-01-17 | 1995-12-27 | Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth. |
Country Status (12)
Country | Link |
---|---|
US (3) | US5665333A (en) |
EP (2) | EP1486197A3 (en) |
JP (1) | JPH10512567A (en) |
CN (1) | CN1176594A (en) |
AT (1) | ATE274339T1 (en) |
AU (1) | AU695467B2 (en) |
BR (1) | BR9510536A (en) |
CA (1) | CA2210261C (en) |
DE (1) | DE69533427T2 (en) |
ES (1) | ES2227565T3 (en) |
MX (1) | MX9705403A (en) |
WO (1) | WO1996022078A1 (en) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5961958A (en) * | 1996-07-16 | 1999-10-05 | Four Star Partners | Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth |
DE59705220D1 (en) * | 1996-11-18 | 2001-12-06 | Gaba Internat Ag Therwil | AMINE HYDROFLUORIDES AND THEIR USE AS ORAL CARE PRODUCTS |
FI106923B (en) * | 1997-01-03 | 2001-05-15 | Cultor Ltd Finnsugar Bioproduc | Use of trimethylglycine in preparations for hygiene and care of the mucous membranes of the body |
US20020018754A1 (en) * | 1999-03-15 | 2002-02-14 | Paul Albert Sagel | Shapes for tooth whitening strips |
US6096328A (en) * | 1997-06-06 | 2000-08-01 | The Procter & Gamble Company | Delivery system for an oral care substance using a strip of material having low flexural stiffness |
US5875799A (en) * | 1997-09-23 | 1999-03-02 | Advanced Medical Instruments, Inc. | Therapeutic dental floss for treating systemic diseases |
US5875798A (en) * | 1997-09-23 | 1999-03-02 | Advanced Medical Instruments, Inc. | Therapeutic toothpick for treating oral and systemic diseases |
GB9726909D0 (en) * | 1997-12-19 | 1998-02-18 | Westone Prod Ltd | Coating of PTFE dental floss |
US6660776B1 (en) * | 1998-01-15 | 2003-12-09 | Pellom McDaniels, III | Composition and method for lubricating and protecting the oral cavity using flavored petroleum jelly |
CN1297347A (en) * | 1998-02-19 | 2001-05-30 | 奥拉修蒂科有限公司 | Antimicrobial denture adhesive composition |
US6123925A (en) * | 1998-07-27 | 2000-09-26 | Healthshield Technologies L.L.C. | Antibiotic toothpaste |
US6436369B2 (en) * | 1998-12-17 | 2002-08-20 | Wm. Wrigley Jr. Company | Anti-plaque emulsions and products containing same |
WO2000038617A2 (en) * | 1998-12-24 | 2000-07-06 | Four Star Partners | Compositions and methods of using the same |
JP4405092B2 (en) | 1999-04-29 | 2010-01-27 | ネクス テクノロジーズ インコーポレイテッド | Interdental surface coating applicator |
US6626961B1 (en) | 2000-04-27 | 2003-09-30 | Kimberly-Clark Worldwide, Inc. | Nonwovens modified with petrolatum |
CA2311278A1 (en) * | 2000-06-09 | 2001-12-09 | Neks Recherche & Developpement Inc. | Applicator and method for applying a sealant on smooth dental surfaces |
JP2004517653A (en) * | 2000-10-24 | 2004-06-17 | ボシュ・アンド・ロム・インコーポレイテッド | Prevention of bacterial adhesion to biomaterials by cationic polysaccharides |
US6702983B2 (en) | 2001-05-15 | 2004-03-09 | Bausch & Lomb Incorporated | Low ionic strength method and composition for reducing bacterial attachment to biomaterials |
US7476697B2 (en) * | 2001-09-10 | 2009-01-13 | Patacca Thomas R | Tooth coating composition |
US20030204180A1 (en) * | 2002-04-30 | 2003-10-30 | Kimberly-Clark Worldwide, Inc. | Temperature responsive delivery systems |
US6949240B2 (en) * | 2002-05-23 | 2005-09-27 | The Procter & Gamble Company | Tooth whitening products |
US8524200B2 (en) | 2002-09-11 | 2013-09-03 | The Procter & Gamble Company | Tooth whitening products |
US7030073B2 (en) * | 2002-09-27 | 2006-04-18 | Mccammon Donald L | Chemical composition |
BR0314952A (en) * | 2002-09-30 | 2005-08-02 | Bausch & Lomb | Method for inhibiting bacteria from adhering to a surface of a biomedical device |
US7645137B2 (en) * | 2002-12-04 | 2010-01-12 | Bryan Wasyluch | Method and apparatus for bleaching teeth |
US8602774B2 (en) | 2002-12-04 | 2013-12-10 | Bryan Wasylucha | Process of tooth whitening and apparatus therefor |
US20040206932A1 (en) | 2002-12-30 | 2004-10-21 | Abuelyaman Ahmed S. | Compositions including polymerizable bisphosphonic acids and methods |
WO2004093643A2 (en) * | 2003-04-16 | 2004-11-04 | The Children's Hospital Of Philadelphia | Magnetically controllable drug and gene delivery stents |
CN1859892B (en) * | 2003-08-12 | 2012-05-16 | 3M创新有限公司 | Self-etching dental compositions and methods |
US9028829B2 (en) * | 2004-02-20 | 2015-05-12 | The Children's Hospital Of Philadelphia | Uniform field magnetization and targeting of therapeutic formulations |
US7846201B2 (en) * | 2004-02-20 | 2010-12-07 | The Children's Hospital Of Philadelphia | Magnetically-driven biodegradable gene delivery nanoparticles formulated with surface-attached polycationic complex |
US8562505B2 (en) | 2004-02-20 | 2013-10-22 | The Children's Hospital Of Philadelphia | Uniform field magnetization and targeting of therapeutic formulations |
US20050205107A1 (en) * | 2004-03-22 | 2005-09-22 | Ochs Harold D | Dental floss head device with a flavor delivery means |
JP5214242B2 (en) | 2004-07-08 | 2013-06-19 | スリーエム イノベイティブ プロパティズ カンパニー | Dental methods, compositions, and kits containing acid-sensitive dyes |
JP5037342B2 (en) | 2004-08-11 | 2012-09-26 | スリーエム イノベイティブ プロパティズ カンパニー | Adhesive composition comprising a plurality of acidic compounds |
JP2008527068A (en) * | 2004-12-30 | 2008-07-24 | ハダシット メディカル リサーチ サーヴィシーズ アンド ディヴェロップメント リミテッド | Antibacterial nanoparticle additives forming non-leaching persistent antibacterial polymer compounds |
SE0403216D0 (en) * | 2004-12-30 | 2004-12-30 | Appeatex Ab | Antimicrobial product |
US20080112902A1 (en) * | 2005-04-25 | 2008-05-15 | Joseph Perechocky | Protective Dental Balm and Method |
US20060239938A1 (en) * | 2005-04-25 | 2006-10-26 | Joseph Perechocky | Dental balm and method of prevention of damage to teeth |
US20060243298A1 (en) * | 2005-04-28 | 2006-11-02 | The Procter & Gamble Company | Dental floss compositions comprising menthol and carboxamides |
US20070087113A1 (en) * | 2005-10-19 | 2007-04-19 | Bausch & Lomb Incorporated | Surface-modified medical devices and method of making |
US7661430B2 (en) * | 2006-05-19 | 2010-02-16 | Richard Mason | Antimicrobial dental appliances including mouthguards and mouthpieces |
CN101557791B (en) | 2006-12-13 | 2013-05-22 | 3M创新有限公司 | Methods of using a dental composition having an acidic component and a photobleachable dye |
US20090198262A1 (en) * | 2006-12-26 | 2009-08-06 | Discus Dental, Llc | Disposable tongue scraper |
US20080181857A1 (en) * | 2007-01-26 | 2008-07-31 | The Procter & Gamble Company | Dental flosses incorporating active agents |
WO2009043031A2 (en) * | 2007-09-27 | 2009-04-02 | Children's Medical Center Corporation | Microbubbles and methods for oxygen delivery |
WO2009073374A2 (en) * | 2007-12-03 | 2009-06-11 | Bausch & Lomb Incorporated | Method for inhibiting attachment of microorganisms to biomedical devices |
US20110236859A1 (en) * | 2008-04-22 | 2011-09-29 | Keleman Bradley R | Oral care composition containing oxidase enzyme |
AU2009282051A1 (en) * | 2008-08-12 | 2010-02-18 | Castle Beach, L.L.C. | Active delivery system formulations |
GB0905864D0 (en) * | 2009-04-03 | 2009-05-20 | Glaxo Group Ltd | Novel use |
US8747814B2 (en) * | 2009-08-17 | 2014-06-10 | The Procter & Gamble Company | Oral care compositions and methods |
BR112012005327A2 (en) * | 2009-09-11 | 2016-03-22 | Procter & Gamble | methods and compositions for hydrophobic modification of buccal cavity surfaces |
US8535058B1 (en) | 2010-01-28 | 2013-09-17 | Pulpdent Corporation | Dental release agent and methods for its use |
EP2854744A4 (en) | 2012-06-01 | 2015-12-16 | Centrix Inc | Protective wax for bleached teeth |
EP2908798B1 (en) | 2012-10-17 | 2018-08-22 | The Procter and Gamble Company | Strip for the delivery of an oral care active and methods for applying oral care actives |
CN105307625B (en) | 2013-06-24 | 2018-10-23 | 宝洁公司 | Antifouling oral care composition |
WO2017145142A1 (en) | 2016-02-25 | 2017-08-31 | Nobio Ltd. | Micro and nanoparticulate compositions comprising anti-microbially active groups |
EP3675801B1 (en) | 2017-08-30 | 2024-01-24 | Nobio Ltd. | Anti-microbial particles and methods of use thereof |
KR102238606B1 (en) * | 2020-11-05 | 2021-04-08 | 한동윤 | metal porcelain artificial tooth manufacturing method using low-temperature surface defect repair technology |
US11931438B2 (en) | 2021-02-03 | 2024-03-19 | Modern Ideas LLC | Silver fluoride formulations, methods and devices for caries management |
Family Cites Families (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US31787A (en) * | 1861-03-26 | Stilt | ||
US2700636A (en) * | 1949-05-14 | 1955-01-25 | Johnson & Johnson | Gum-impregnated dental floss |
US2684924A (en) * | 1951-02-05 | 1954-07-27 | Ici Ltd | Nu-chlorophenyldiguanidino compounds |
US2984639A (en) * | 1953-12-31 | 1961-05-16 | Crusader Chemical Co Inc | Composition comprising the reaction product of a quaternary ammonium compound and a polymer of ethylenically unsaturated monomer |
US2990425A (en) * | 1956-06-06 | 1961-06-27 | Ici Ltd | New biguanide salts |
BE612529A (en) * | 1961-01-13 | |||
US3325402A (en) * | 1964-01-17 | 1967-06-13 | Erskine Archibald Mortimer | Adsorption complexes of activated carbon with insoluble antimicrobial compounds |
US3431208A (en) * | 1965-11-17 | 1969-03-04 | Schering Corp | Denture spray |
US3468898A (en) * | 1966-05-26 | 1969-09-23 | Sterling Drug Inc | Bridged bis-biguanides and bis-guanidines |
US3468989A (en) * | 1966-11-25 | 1969-09-23 | Dow Chemical Co | High density surface for foamed inorganics |
FR2000422A1 (en) * | 1968-01-19 | 1969-09-05 | Kenner Products Cy | Modelling paste contg. mineral wax, pref. microcrystalline - plasticiser, pref. eicosane and filler |
US3671626A (en) * | 1970-12-14 | 1972-06-20 | Gillette Co | Inhibiting dental plaque |
CH550586A (en) * | 1971-04-08 | 1974-06-28 | Espe Pharm Praep | Mucous membrane flushing and cleaning agents. |
US3703583A (en) * | 1971-06-10 | 1972-11-21 | Lever Brothers Ltd | Anticalculus formulations |
GB1351903A (en) * | 1971-06-11 | 1974-05-01 | Fmc Corp | Cosmetic and pharmaceutical compositions |
US4022834A (en) * | 1972-03-16 | 1977-05-10 | A/S Farmaceutisk Industri | Antibacterially active hexamethylene-bis-biguanides |
US4102827A (en) * | 1973-12-26 | 1978-07-25 | California Institute Of Technology | Novel polyelectrolytes |
US4020019A (en) * | 1975-01-29 | 1977-04-26 | Gianluigi Soldati | Anticaries agents |
US4029113A (en) * | 1975-02-20 | 1977-06-14 | William Cecil Guyton | Waxed dental textile material and method of preparing and using the same |
DE2626935A1 (en) * | 1976-06-16 | 1977-12-29 | Dolorgiet Arzneimittelfabrik | DISINFECTANTS |
US4053636A (en) * | 1976-05-24 | 1977-10-11 | Sterling Drug Inc. | Dichlorocyclopropylphenyl bisbiguanide compounds, processes and compositions |
DE2712161C2 (en) * | 1977-03-19 | 1983-01-05 | Blendax-Werke R. Schneider Gmbh & Co, 6500 Mainz | Dental and oral care products |
JPS53147073A (en) * | 1977-05-24 | 1978-12-21 | Sankyo Co Ltd | Mevalonolactone derivatives |
GB2001526A (en) * | 1977-07-26 | 1979-02-07 | Warner & Co Ltd W | Dentifrice containing hexetidine and fluorides |
US4157386A (en) * | 1978-05-18 | 1979-06-05 | Rochelle Paul J | Soft, chewable lozenge forming a sticky coating on teeth when combined with saliva in the mouth which is removable only by brushing |
US4205061A (en) * | 1978-07-14 | 1980-05-27 | Johnson & Johnson | Oral antimicrobial compositions |
USRE31787E (en) * | 1979-04-02 | 1985-01-01 | Minnesota Mining And Manufacturing Company | Compositions for reducing elution of therapeutic agents from teeth |
SU821626A1 (en) * | 1979-05-28 | 1981-04-15 | Белорусский Технологический Ин-Ститут Им. C.M.Кирова | Paper and board sizing composition |
DE2925020A1 (en) * | 1979-06-21 | 1981-01-08 | Wybert Gmbh | Toothpick impregnated with anticariogenic agent - pref. with amine hydro:fluoride used for protection against caries in inter-dental spaces |
EP0026539B2 (en) * | 1979-10-02 | 1989-10-18 | Gaba International AG | Oral compositions with stabilized tin salts |
GB2084870B (en) * | 1980-10-10 | 1985-05-09 | Muhlemann R Hans | Oral compositions containing pyrimidine amine compounds and zinc salts |
US4428930A (en) * | 1981-09-18 | 1984-01-31 | Minnesota Mining And Manufacturing Company | Compositions and method for reducing elution of therapeutic agents from teeth |
US4485090A (en) * | 1981-09-18 | 1984-11-27 | Minnesota Mining And Manufacturing Company | Composition and method for reducing elution of therapeutic agents from teeth |
US4504228A (en) * | 1982-03-09 | 1985-03-12 | Daikin Kogyo Co., Ltd. | Dental casting |
US4490353A (en) * | 1983-07-13 | 1984-12-25 | Colgate-Palmolive Company | Antiplaque dentifrice with improved fluoride stability |
US4528182A (en) * | 1983-07-13 | 1985-07-09 | Colgate-Palmolive Company | Stable antiplaque dentifrice with improved foaming |
SU1251904A1 (en) * | 1984-03-07 | 1986-08-23 | Центральный Научно-Исследовательский Институт Стоматологии Мз Ссср | Composition for mineralization of teeth |
US4752485A (en) * | 1984-10-05 | 1988-06-21 | Warner-Lambert Company | Novel sweetener delivery systems |
US4797288A (en) * | 1984-10-05 | 1989-01-10 | Warner-Lambert Company | Novel drug delivery system |
US4776358A (en) * | 1986-09-23 | 1988-10-11 | Leonard Lorch | Floss employing microporous tapes sandwiching paste dentifrice |
US5344641A (en) * | 1987-01-30 | 1994-09-06 | Colgate-Palmolive Co. | Antibacterial antiplaque oral composition |
US5209251A (en) * | 1988-03-29 | 1993-05-11 | Colgate-Palmolive Company | Dental floss |
US5033488A (en) * | 1988-03-29 | 1991-07-23 | Colgate-Palmolive Co. | Dental floss |
FR2631823B1 (en) * | 1988-05-30 | 1992-05-29 | Dana Dominique | NEW TOOTHPASTE COMPOSITION |
GB8819873D0 (en) * | 1988-08-22 | 1988-09-21 | Westone Prod Ltd | Dental floss & tape |
US5174313A (en) * | 1988-09-13 | 1992-12-29 | Rosenberger Edwin D | Germicidal dental floss and method for fabrication |
US4911927A (en) * | 1988-11-14 | 1990-03-27 | Hill Ira D | Method and apparatus for adding chemotherapeutic agents to dental floss |
US5165913A (en) * | 1988-11-14 | 1992-11-24 | Ira Hill | Controlled release interproximal delivery system |
FR2648346B1 (en) * | 1989-06-20 | 1993-10-08 | Dana Dominique | SOLID TOOTHPASTE COMPOSITIONS |
EP0408174A1 (en) * | 1989-07-12 | 1991-01-16 | Warner-Lambert Company | Antiseptic composition containing hexahydro-5-pyrimidinamine compounds |
AU642980B2 (en) * | 1990-03-21 | 1993-11-04 | Quest International B.V. | Ultilization of enzymes |
JPH03293024A (en) * | 1990-04-11 | 1991-12-24 | Nikko Kemikaruzu Kk | Water-in-oil type emulsion with lecithin dispersed in water phase |
IL94294A (en) * | 1990-05-04 | 1992-11-15 | Hamivreshet Brush Factory Kibb | Toothbrush |
US5340581A (en) * | 1991-08-23 | 1994-08-23 | Gillette Canada, Inc. | Sustained-release matrices for dental application |
US5300305A (en) * | 1991-09-12 | 1994-04-05 | The Procter & Gamble Company | Breath protection microcapsules |
AU675206B2 (en) * | 1991-09-13 | 1997-01-30 | Gillette Canada Inc. | Polymeric particles for dental applications |
WO1993020775A1 (en) * | 1992-04-22 | 1993-10-28 | Dunton Ronald K | Composition containing particles of fluorinated polyethylene useful for coating the surface of a substrate |
US5290541A (en) * | 1992-06-18 | 1994-03-01 | The Procter & Gamble Company | Methods for making oral compositions |
ZA94438B (en) * | 1993-02-19 | 1994-08-29 | Warner Lambert Co | Pre-brushing rinse composition |
-
1995
- 1995-01-17 US US08/373,946 patent/US5665333A/en not_active Expired - Lifetime
- 1995-06-07 US US08/479,210 patent/US5888480A/en not_active Expired - Lifetime
- 1995-12-27 EP EP04019582A patent/EP1486197A3/en not_active Withdrawn
- 1995-12-27 AT AT95944124T patent/ATE274339T1/en not_active IP Right Cessation
- 1995-12-27 DE DE69533427T patent/DE69533427T2/en not_active Expired - Lifetime
- 1995-12-27 MX MX9705403A patent/MX9705403A/en unknown
- 1995-12-27 AU AU46005/96A patent/AU695467B2/en not_active Expired
- 1995-12-27 WO PCT/US1995/016393 patent/WO1996022078A1/en active IP Right Grant
- 1995-12-27 CA CA002210261A patent/CA2210261C/en not_active Expired - Lifetime
- 1995-12-27 JP JP8522253A patent/JPH10512567A/en active Pending
- 1995-12-27 ES ES95944124T patent/ES2227565T3/en not_active Expired - Lifetime
- 1995-12-27 CN CN95197676.1A patent/CN1176594A/en active Pending
- 1995-12-27 BR BR9510536A patent/BR9510536A/en not_active Application Discontinuation
- 1995-12-27 EP EP95944124A patent/EP0805672B1/en not_active Expired - Lifetime
-
1996
- 1996-03-22 US US08/620,361 patent/US5980868A/en not_active Expired - Lifetime
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA97005403A (en) | Methods, compositions and distribuciondental systems for the protection of dien surfaces | |
US5665333A (en) | Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth | |
US5961958A (en) | Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth | |
WO1998002136A9 (en) | Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth | |
Netuschil et al. | Plaque bacteria counts and vitality during chlorhexidine, meridol and listerine mouthrinses | |
CA2781384C (en) | Biofilm disruptive compositions | |
Paraskevas | Randomized controlled clinical trials on agents used for chemical plaque control | |
FI99259C (en) | Dental plaque reducing tooth cleaner | |
AU2009282051A1 (en) | Active delivery system formulations | |
CA2104462A1 (en) | Oral and personal hygiene articles containing active agents bonded to the surface thereof | |
NZ227596A (en) | Oral hygiene composition comprising a cationic antibacterial agent and a polymer bearing pendant polyalkylene oxide side chains | |
CN110023471B (en) | Cleaning composition | |
KR20080049158A (en) | Composition for cleaning toothbrush | |
JP6604848B2 (en) | Protection of materials by sphingosine compounds | |
JP3006960B2 (en) | Oral composition | |
EP4312967A1 (en) | Oral cavity cleaning composition, method, and apparatus | |
JPH0624950A (en) | Composition for oral cavity |